Stock Market Today 12.12.2025

Nasdaq 100 Movers: LULU Leads Early Gains as AVGO Drops; SMCI and WBD Move

December 12, 2025, 1:23 PM EST. In early trading, lululemon athletica (LULU) topped the Nasdaq 100 movers as shares rise about 2.3% for the session. Year-to-date, LULU has fallen roughly 49.2%. On the other side, Broadcom (AVGO) is down about 8.5% today, though it remains up around 25.2% YTD. Also moving were Super Micro Computer (SMCI), down roughly 5.2%, and Warner Bros. Discovery (WBD), up about 2.2%. The day’s moves underscore ongoing rotation within the Nasdaq 100 as investors weigh valuation, sector momentum, and the appeal of quality names amid a volatile market.

Friday Insider Buying Report: Notable Purchases in GPN and ZEUS

December 12, 2025, 1:22 PM EST. Friday’s insider action highlights two notable buys in GPN and ZEUS. Global Payments director Robert H. B. Baldwin Jr. purchased 13,392 shares at $81.16 ($1.09M), with the position in the green as GPN trades near session highs (~+2.8%). He previously bought $672,800 worth at $116.00 per share in the past year. On the Olympic Steel side, director Peter Jennings Scott bought 5,030 shares at $39.89 ($200,647)-the first filing in twelve months. ZEUS has risen about 0.9% on the day, with intraday highs near $43.26. These insider purchases suggest confidence in near-term performance, though insider activity is not a guarantee of future results.

Radcom RDCM Price and P/E Analysis: Is the Stock Undervalued Relative to Software Peers?

December 12, 2025, 1:21 PM EST. Radcom Inc. (NASDAQ: RDCM) is trading at $12.01 after a 12.46% drop in the current session. Over the last month the stock rose 4.52%; over the past year it gained 15.50%. The focus is Radcom‘s valuation through the P/E ratio, which is lower than the Software industry aggregate of 105.61, suggesting potential undervalued status or slower growth expectations. A lower P/E ratio can signal discounting of future earnings or muted outlook, but it should not be relied on in isolation. Investors typically weigh future growth, dividends, and industry trends alongside the P/E when evaluating RDCM relative to peers. The piece emphasizes using qualitative factors and broader market cycles in addition to numerical metrics.

Sun Life Financial (SLF) crosses above 200-day moving average, hits $60.35

December 12, 2025, 1:16 PM EST. Sun Life Financial Inc (SLF) crossed above its 200-day moving average of $60.00 on Friday, trading as high as $60.35 and advancing about 0.8% on the session. The last trade was around $60.20, with the stock lingering within its 52-week range of $52.44-$66.81. A breakout above the 200-day MA can be a bullish signal, potentially paving the way for additional upside toward the recent high, though near-term resistance may appear near the $66.81 level. Traders may await follow-through volume to confirm the breakout in the coming sessions.

Enerpac Tool Group crosses above 200-day moving average signals bullish move (EPAC)

December 12, 2025, 1:15 PM EST. Enerpac Tool Group Corp (EPAC) edged higher after its shares crossed above the 200-day moving average of $41.22 on Friday, trading up as high as $41.26. The stock was about +2.6% on the day, with a last trade near $41.24. The chart highlights a one-year view of EPAC versus the moving average. In the past year, the 52-week range spans $36.51 to $49.40. This latest cross above the moving average is interpreted as a bullish signal by technicians, suggesting potential continued strength if momentum persists. Investors should watch for follow-through intraday action and volume to confirm the trend.

TGT February 2026 Options Debut Offers YieldBoost Premium Opportunities

December 12, 2025, 1:10 PM EST. Target Corp (TGT) kicked off trading for the February 2026 options, unveiling potential YieldBoost opportunities for option sellers and strategists. The put at the $95 strike bids around $3.50, implying a cost basis of $91.50 if sold to open-roughly a 3% discount to the current price and about a 60% chance the option expires worthless. That scenario yields roughly a 3.68% return on cash (19.21% annualized). On the call side, the $100 strike bids about $4.45; a covered call, buying at $97.68 and selling the call, could deliver around 6.93% if the stock ends up called away. Stock Options Channel tracks the odds and includes charted histories of TGT for context.

TGT February 2026 Options Begin Trading: Put 95 and Call 100 Attract Premiums

December 12, 2025, 1:09 PM EST. Investors in Target Corp (TGT) saw new February 2026 options begin trading, with 70 days to expiration creating richer time value for sellers of puts or calls. The put at $95 strike shows a current bid of $3.50. Selling to open puts would commit to buying the stock at $95, funded by the premium for a cost basis of $91.50 (pre-commissions)-roughly a 3% discount to the current price, and a roughly 60% odds the put expires worthless. The YieldBoost analytics also track this probability via a live chart. On the call side, the $100 strike bid is $4.45. A covered-call approach, buying at about $97.68 and selling the call, implies about 6.93% total return if shares are called away at expiration, excluding dividends. The piece also notes potential upside and the importance of fundamentals.

Aon (AON) March 2026 Options Debut: YieldBoost Highlights 330 Put and 360 Call

December 12, 2025, 1:08 PM EST. Investors gained access to March 2026 options for Aon plc (AON) with 98 days to expiry. The YieldBoost data highlights a 330.00 put bid at $6.00. Selling to open this put would establish a $324.00 effective cost basis if assigned, offering a potential hedge against the current $349.51 stock price and a roughly 6% discount. The odds of the put expiring worthless are about 72%, implying a 1.82% return on cash and roughly 6.77% annualized if the premium is kept. On the call side, the 360.00 call bids at $10.10. A covered call using stock at $349.51 and selling that call offers about 5.89% total return if the stock is called away at expiration, while leaving upside potential. The article also references trailing twelve-month charts on the contract detail pages.

March 2026 Options Open for Aon: YieldBoost Highlights on $330 Put and $360 Call

December 12, 2025, 1:07 PM EST. Investors in Aon plc (AON) gained new March 2026 options, expanding the potential for premium collection. The put at $330 offers a current bid around $6.00, implying a cost basis of about $324.00 if sold to open, about a 6% discount to the current price (~$349.51). With current odds around 72% that the put expires worthless, the premium could yield roughly 1.82% on cash, or 6.77% annualized (YieldBoost) if the contract expires worthless. On the call side, the $360 strike bid is around $10.10; a covered call using current price and selling that contract could produce about 5.89% total return if called away at expiration, albeit with upside capped. Traders should consider the history and fundamentals.

RF March 2026 Options Begin Trading: YieldBoost on the $28 Covered Call

December 12, 2025, 1:06 PM EST. Regions Financial Corp (RF) saw new March 2026 options begin trading, offering a potential covered-call setup. With ~98 days to expiration, a $28.00 call currently bids 10 cents. A plan to buy RF at $27.70 and sell-to-open the $28 call as a covered call could deliver a total return of about 1.44% if RF is called away at expiry, excluding commissions. If shares stay in place or rally, upside may be capped, which is offset by a 48% chance the option expires worthless, yielding a roughly 0.36% premium boost or about 1.35% annualized as a YieldBoost. The deal reflects an implied volatility around 32% versus ~30% trailing twelve month volatility. Traders may monitor the contract’s probability of profit and historical trade data on Stock Options Channel for evolving odds.

RF March 2026 Options Begin Trading: Covered Call Opportunity on Regions Financial

December 12, 2025, 1:05 PM EST. Regions Financial Corp (RF) saw new March 2026 options begin trading, offering a potential covered call setup. With ~98 days to expiration, the $28 strike call shows a current bid of $0.10, while RF trades near $27.70. A buy-and-hold investor who sells this call against the stock could target a total return of about 1.44% if the stock is called away at expiration (before commissions). If the option expires worthless, the premium boosts return by 0.36% (roughly 1.35% annualized as a YieldBoost). The contract’s implied volatility is around 32%, versus a trailing 12-month volatility of 30%. Odds of expiry worthless sit near 48% today, with tracking charts available on Stock Options Channel.

AJG March 2026 Options Spotlight: Put at 250 and Covered Call at 260 with YieldBoost

December 12, 2025, 1:04 PM EST. Arthur J. Gallagher & Co. (AJG) reveals new March 2026 options, presenting opportunities for premium collection. The $250 put bids at $11.10, implying a cost basis of $238.90 if sold to open and about a 57% chance it expires worthless, a potential 4.44% return on cash (≈16.54% annualized) per YieldBoost. On the call side, the $260 strike bids $9.60; selling a covered call after buying at $251.38 could yield roughly 7.25% if the stock is called away at expiration. Stock Options Channel will track the odds and greeks over time and publish a chart on the contract’s detail page. Investors should consult AJG’s trailing twelve month trading history and fundamentals when evaluating these setups.

AJG March 2026 Options Highlight: Put at $250 and Covered Call at $260 Offer YieldBoost Opportunities

December 12, 2025, 1:03 PM EST. Arthur J. Gallagher & Co. (AJG) introduced new March 2026 options. The put at the $250 strike carries a bid of $11.10, implying a cost basis of $238.90 if sold to open. With the stock around $251.38, the strike sits about 1% out-of-the-money, offering a roughly 57% odds the put expires worthless and a potential 4.44% premium return (16.54% annualized) on the cash at risk, per YieldBoost. On the call side, the $260 strike has a bid of $9.60. A covered call using 1) owning AJG at current levels and 2) selling this call could yield about 7.25% if the stock is called away at expiration. Investors should weigh upside potential against the premiums and fundamentals.

February 2026 Verizon Options Open: Potential Covered Call on VZ at $45

December 12, 2025, 1:02 PM EST. Verizon Communications (VZ) has new February 2026 options. With ~70 days to expiration, a notable setup is selling-to-open a covered call at the $45 strike. The current VZ price is about $40.67, so selling the call aims to lock in a ~10.92% total return if the stock is called away at expiration, excluding commissions. The $45 strike implies roughly an 11% premium to the current price. The options odds of expiring worthless are shown around 74%, and a worthless expiry would boost the return by about 0.27% (1.41% annualized) per YieldBoost. Implied volatility is 22%, and trailing 12-month volatility matches at 22%. Data from StockOptionsChannel.com.

Verizon (VZ) February 2026 Options Debut: Covered Call at $45 Strike Potentially Yields ~11% Premium

December 12, 2025, 1:01 PM EST. Verizon Communications Inc. (VZ) has new February 2026 options trading, about 70 days to expiration. A highlighted opportunity from Stock Options Channel shows a covered call using the $45 strike. With VZ near $40.67, selling to open that call could lock in a premium of 11 cents and a potential total return of about 10.92% if the stock is called away at expiration (ignoring dividends). The odds of the option expiring worthless are roughly 74%, and the implied volatility is 22%-roughly matching a trailing twelve-month volatility around 22%. If expired worthless, the premium adds about 0.27% boost (≈ 1.41% annualized) per YieldBoost metrics.

Stock Market Live December 12: Trump to Ease Marijuana Regulation; S&P 500 (VOO) Flat

December 12, 2025, 1:00 PM EST. Live market updates show VOO and the S&P 500 drifting premarket after the latest headlines. The biggest item: The Washington Post reports Trump plans to reclassify marijuana to Schedule III, easing possession restrictions. In earnings news, Johnson Outdoors (JOUT) missed estimates with a Q4 loss of $2.83 per share on $135.8M revenue, while Costco (COST) beat on $4.50 per share revenue of $67.3B; same-store sales rose 6.4% y/y and e-commerce climbed, yet shares traded lower. Markets also weighed prior Fed rate moves; the VOO/S&P 500 remain flat on the day. Updates will continue throughout the session.

LHX March 2026 Options Debut: 290 Put and 300 Call Offer YieldBoost Opportunities

December 12, 2025, 12:59 PM EST. L3Harris Technologies (LHX) saw new options trading for the March 2026 expiration. A $290 put bids at $11.90, which implies a cost basis of $278.10 if you sell-to-open and are assigned, about a 1% discount to the current price around $291.80. If the put expires worthless, it delivers a 4.10% return on cash and roughly 15.3% annualized (YieldBoost). The current odds of that outcome are about 56%. On the call side, the $300 strike bids around $10.70. A covered call (buy the stock near $291.80 and sell the $300 call) could generate about 6.48% total return if called away at expiration, excluding dividends. A chart highlights the $290 and a trailing twelve month history to contextualize the move.

GLD November 2026 Options: 395 Put Attracts Premium, 430 Call For Covered-Call

December 12, 2025, 12:58 PM EST. GLD’s new November 2026 options window features a put at the $395 strike with a current bid of $23.40. Selling to open would lock in a cost basis of $371.60 per share (plus commissions) if assigned, about a 1% discount to the current price. The odds of the put expiring worthless are about 63%, per YieldBoost, with that outcome yielding about 5.92% on cash and roughly 6.30% annualized. On the call side, the $430 strike bid is $25.00. A covered-call on GLD at a current price around $397.89 could deliver about 14.35% total return if called away at expiration. Traders will watch how these odds and greeks evolve over the next 343 days.

PRM December 2026 Options Begin Trading: YieldBoost Highlights Put and Covered-Call Plays

December 12, 2025, 12:57 PM EST. Perimeter Solutions Inc (PRM) saw new December 2026 options begin trading with 371 days to expiration. Stock Options Channel’s YieldBoost flags a $25 put (bid $1.70) that allows selling to open and purchasing PRM at $25, yielding a cost basis of $23.30 if assigned. With the current price around $28.90, the $25 strike is about a 13% discount and the odds of expiring worthless are about 73%, implying a potential 6.80% return on cash (6.69% annualized) if the option expires worthless. On the call side, the $30 strike bid is $3.90; a covered call using PRM stock could deliver ~17.30% total return if the stock is called away at expiration. Charts illustrate the two strike levels relative to PRM’s trailing twelve month history.

MAT March 2026 Options Highlight: 20 Put & 22 Call YieldBoost Opportunities

December 12, 2025, 12:56 PM EST. Stock Options Channel flags two March 2026 Mattel (MAT) contracts as noteworthy. A $20.00 put (bid 0.25) offers an implied cost basis of $19.75 when sold to open, with about 63% odds of expiring worthless and a 1.25% return on cash (4.66% annualized) via YieldBoost. On the call side, a $22.00 call (bid 0.40) could be used in a covered-call: buy MAT around $20.80 and sell the call for roughly 7.69% total return if shares are called away, which reflects about a 6% premium to the current price. The analysis also notes tracking the odds and monitoring MAT’s 98 days to expiration and the stock’s trailing history.

Ex-Dividend Reminder: Prologis (PLD), Bain Capital Specialty Finance (BCSF) and AIG

December 12, 2025, 12:55 PM EST. Dividend Channel flags ex-dividend dates for Prologis (PLD), Bain Capital Specialty Finance (BCSF) and American International Group (AIG) on 12/16/25. Prologis will pay a quarterly dividend of $1.01 on 12/31/25; Bain Capital Specialty Finance $0.42 on 12/30/25; AIG $0.45 on 12/30/25. At PLD’s recent price of $130.56, the payout implies about 0.77%; BCSF about 2.90%; and AIG about 0.54% open-price moves, all else equal. Current estimates show annual yields of 3.09% (PLD), 11.59% (BCSF) and 2.17% (AIG) if dividends persist. On Friday, PLD rose about 0.7%, BCSF fell about 0.7%, and AIG gained about 2.2%.

March 2026 Options Now Available for Ascendis Pharma (ASND) – YieldBoost Highlights

December 12, 2025, 12:54 PM EST. Ascendis Pharma (ASND) launched new March 2026 options, with a $210 put and a $220 call. A Sell-to-open put at $210 implies a basis of about $190 if assigned, roughly a 2% discount to the current price and a 56% chance the option expires worthless, yielding about 9.52% on cash (or 35.49% annualized) as part of Stock Options Channel’s YieldBoost framework. The $220 call offers a potential 10.93% total return on a covered-call setup if the stock is called away at expiration, assuming the stock at $213.19 today. Charts highlight the 12-month trading history and how the strikes sit relative to recent price action; deeper fundamentals remain a consideration for prospective traders.

Ex-Dividend Reminder: STMicroelectronics, Amphenol and Hillenbrand Go Ex-Dividend on 12/16/25

December 12, 2025, 12:53 PM EST. On 12/16/25, STM, APH, and HI go ex-dividend. STM will pay $0.09 per share (approx. 0.34% of $26.26), APH $0.25, and HI $0.2275. Implied annual yields are roughly 1.37% for STM, 0.72% for APH, and 2.86% for HI based on recent prices. If dividends continue, these yields may change; stocks typically trade lower by the dividend amount on ex-date. Consult latest declarations before trading.

Ecolab (ECL) Ex-Dividend on 12/16/25 – Quarterly Dividend $0.73

December 12, 2025, 12:52 PM EST. Ecolab Inc (ECL) goes ex-dividend on 12/16/25 with a quarterly payout of $0.73 per share, payable 1/15/26. At a price around $261.33, the ex-dividend yield sits near 0.28%, with a rough annual yield near 1.12%. History and the one-year chart suggest the trend remains consistent, though dividends are not guaranteed. The stock’s 52-week range runs from $221.62 to $286.04, with the latest trade at $262.65 and Friday shares up about 1.5%. Investors should weigh the modest yield against potential capital gains, and consider this alongside peers cited in the SAFÉ dividend stock list.

AIN Ex-Dividend Reminder: Albany International Stock Set to Trade Ex-Dividend on 12/16/25

December 12, 2025, 12:51 PM EST. AIN Ex-Dividend Reminder: Albany International Corp (AIN) will trade ex-dividend on 12/16/25 for its quarterly dividend of $0.28 per share, payable 1/8/26. At a recent price of $53.08, this implies an approximate 0.53% ex-dividend impact at the open, all else equal. The current estimated annual yield is ~2.11%. The stock’s one-year view versus its 200-day moving average shows movement within the range; the 52-week low/high are $41.15 and $83.65, with the last trade around $53.76. In Friday trading, AIN was up about 3.5%. Remember that dividend timing and amounts can change, so use this as a guide and check the latest payout details.

Costco Stock Outlook Dec 12, 2025: Earnings Beat, Value + Volume, Tariff Risks

December 12, 2025, 12:50 PM EST. Costco posted a stronger-than-expected first-quarter 2026 with net sales of $65.98 billion, up 8.2%, and EPS of $4.50. Analysts note the beat reinforces the value + volume model, aided by Kirkland Signature and rising digital commerce (+20.5% digitally-enabled comps). Despite the headline beat, shares have cooled as investors weigh growth normalization against a premium multiple and tariff policy risks. November sales showed +8.1% and comps +6.9%, underscoring real traffic gains rather than one-off timing. The key question: can Costco sustain mid-single-digit comps without heavy discounting? Bulls point to healthy private-label demand and steady traffic; bears fear multiples compression if growth slows or tariff headwinds intensify. Expect volatility around guidance and macro signals.

Verizon vs American Tower: Which Is the Smarter 5G Bet for 2026?

December 12, 2025, 12:48 PM EST. Verizon (VZ) is betting on a robust 5G portfolio built on massive spectrum, deep fiber resources, and a dense small-cell rollout to fuel faster speeds and expanding fixed wireless broadband. Its growth plan blends 5G mobility with nationwide broadband, edge compute, and new enterprise offerings in cloud and security, while market promotions threaten near-term margins as rivals like AT&T and T-Mobile accelerate fiber densification. American Tower (AMT), by contrast, sits on the backbone of 5G densification: a leading independent tower operator that rents space to wireless carriers and other tenants, offering steady cash flows as demand for towers grows. The smarter 5G bet for 2026 will hinge on who converts incremental 5G demand into durable, high-quality earnings and cash flow, with competitive risks from pricing and capex.

Ciena, Planet Labs Rally on Earnings Beats; Disney and Adobe React to OpenAI Investment

December 12, 2025, 12:47 PM EST. Markets moved higher as earnings beats sparked gains. CIEN jumped 9.3% after reporting Q4 fiscal 2025 earnings of $0.91 per share, topping the Zacks consensus of $0.77. PL surged 35% after Q3 fiscal 2026 revenues of $81.3 million beat the $71.9 million estimate. ADBE rose 2.1% after Q4 fiscal 2025 earnings of $5.50 per share, above $5.39 expected. DIS advanced 2.4% on news of a $1 billion equity investment in OpenAI. Zacks Research Chief Sheraz Mian highlights a top pick with potential to double among a list of recommendations.

ExxonMobil Accelerates Permian Growth to 2.3 Million Barrels per Day by 2030

December 12, 2025, 12:46 PM EST. ExxonMobil is accelerating Permian growth, targeting 2.3 million barrels per day by 2030 as it expands Midland Basin acreage and deploys new tech. In Q3, Permian output was a record ~1.7 million boe/d, aided by a low-cost refinery coke-based lightweight proppant that lifted recovery by ~20%. The company also added 80,000 net acres from Sinochem. Exxon’s Permian push supports longer-term value beside peers ConocoPhillips (COP) and Chevron (CVX). Over the past year, stock has outpaced the sector (+7.8% vs +6.5%). Valuation remains a focus as XOM trades on trailing twelve months metrics.

Goldman Sachs sees a strong 2026 for stocks, with S&P 500 around 7,600 as AI lifts earnings

December 12, 2025, 12:45 PM EST. Goldman Sachs’ Ben Snider expects a constructive 2026 for equities, setting a S&P 500 target of about 7,600 – roughly +10% from recent levels. He projects 2026 EPS around $305, up about 12%, with most growth coming from six Big Tech names: Nvidia, Apple, Microsoft, Alphabet, Broadcom and Meta. AI adoption should boost productivity and earnings, though his margin model implies more modest expansion for the median stock. The thinker’s view aligns with a broader bullish mood, while other strategists tout targets near 7,700-8,100. Risks include the Fed’s policy path and the sustainability of profit margins amid AI competition. Still, macro tailwinds could lift earnings across the market, including the 493 non-Big Tech names, from +7% in 2025 to around +9% in 2026.

Fermi Falls After AI Campus Tenant Ends $150 Million Deal

December 12, 2025, 12:42 PM EST. Fermi Inc. shares tumbled as much as 43% after a tenant terminated an Advance in Aid of Construction Agreement worth up to $150 million tied to its proposed AI campus in West Texas. The deal would have funded construction costs, though no funds were drawn. Fermi says it has begun talks with other potential electricity customers and remains on track to begin power delivery in 2026. The setback comes as Fermi seeks to build what it described as the world’s largest private power grid for data centers, a project that drew attention during a surge after its IPO. Investors remain wary of potential bubbles in AI infrastructure and intensifying competition from other developers.

Dow Rises as AI Trade Faces Reality Check; S&P 500 and Nasdaq Slip at Opening

December 12, 2025, 12:41 PM EST. U.S. stocks opened mixed as investors weighed AI spending worries against a macro backdrop. The Dow Jones rose about 0.2%, while the S&P 500 slipped roughly 0.2% and the Nasdaq fell around 0.4%, as traders reassessed profitability in AI-heavy names. Broadcom warned that higher-margin demand could pressure margins even with a $73 billion backlog to ship over 18 months. Oracle‘s capital-expenditure surge kept the AI narrative in focus, amplifying debate over whether the rally is pricing perfection or awaiting visible cash flow. Still, analysts note leadership rotation rather than a market collapse, with the broader market showing resilience amid tech jitters and a busy week of Fed commentary and policy headlines.

Rocket Lab Stock Climbs as Electron Mission ‘Bridging The Swarm’ Moves Ahead of Schedule

December 12, 2025, 12:40 PM EST. Rocket Lab (RKLB) stock rose about 2% in premarket trading after the company moved the South Korean Earth-imaging mission ‘Bridging The Swarm’ into the next available launch window. The Electron mission, carrying KAIST‘s NEONSAT-1A, is slated to lift off from Launch Complex 1 on New Zealand’s Māhia Peninsula no earlier than Thursday, Dec. 11, at 12:45 a.m. UTC. NEONSAT-1A will validate imaging performance and help build a multi-satellite constellation for disaster monitoring and environmental surveillance. The move ahead of a previously scheduled JAXA flight highlights Rocket Lab’s launch flexibility. Investors sent shares up about 2% to roughly $54 in premarket trading. The mission supports KAIST’s efforts to enhance image collection for civic planners, emergency workers, and national security, underscoring demand for fast-reaction mini satellites.

Soybeans edge lower to start Friday as export demand mixes with supply concerns

December 12, 2025, 12:39 PM EST. Soybeans are trading lower to start Friday, with nearby futures down about 8-9 cents as traders weigh export data against supplies. Thursday’s session showed light gains in nearby contracts (1-2.25 cents) while the cmdtyView cash price rose to $10.22 1/2. Soymeal futures were up 30-90 cents and Soy Oil futures fell 23-29 points. Overnight deliveries ran 26 contracts for December soybean meal and 34 for bean oil as December expiry nears. The week ending Nov 13 export sales totaled 695,598 MT, lifting accumulated commitments to 18.4 MMT but still about 37.5% below a year ago, with China purchases totaling 3.37 MMT. September shipments highlighted a strong export pace, with 2.856 MMT shipped and meal setting a monthly record.

Hogs Rally as Thursday Gains Lift Lean Hog Futures and Export Demand

December 12, 2025, 12:38 PM EST. Lean hog futures extended Thursday gains, with contracts up 85 cents to about $1.85. The USDA base hog price rose to $71.69 per cwt, up $1.64. The CME Lean Hog Index was up $0.27 to $82.16. Export data showed 2025 pork exports at 23,606 MT and 2026 at 3,947 MT, with shipments of 32,132 MT-the strongest since June. The pork carcass cutout value climbed $1.57 to $98.84 per cwt as all primals advanced, led by the butt and belly. Slaughter pace remained firm, with federal inspected hogs at 494,000 for Thursday and a week-to-date total of 1.965 million. The market is tracking demand into year-end amid steady export momentum.

Friday Corn Edges Lower Ahead of December Expiry as Export Demand Remains Strong

December 12, 2025, 12:37 PM EST. Friday morning, corn prices edge lower 1-2 cents in the front months as December futures approach expiration. Thursday saw higher trade, with nearby contracts up to 2½ cents. The CmdtyView national cash price was about $4.01 1/2 per bushel. New export sales data show 2.38 MMT sold in the week ending 11/13, up 59.3% from a year ago, while total commitments sit 40.7 MMT (1.6 bbu), a record pace. September exports were a record 6.978 MMT, with distillers and ethanol shipments also large. The market kept a cautious tone ahead of the December expiry, with nearby futures posting modest gains on Thursday and mixed moves for the longer maturities.

Newmont Corporation (NEM) Buy Now? Zacks Rank Signals Positive Earnings Revisions

December 12, 2025, 12:34 PM EST. Newmont Corporation (NEM) has trended as one of Zacks.com’s most searched stocks. Over the past month, NEM returned +2.8% vs the S&P 500’s +6.4% and the Mining-Gold group +4.1%. The key driver for near-term moves is shown in earnings estimate revisions. Zacks emphasizes that the present value of future earnings guides fair value, and a rise in estimates often lifts the price. For the current quarter, Newmont is expected to report earnings of $0.82 per share, up 127.8% year over year; the consensus for the full year stands at $3.10, up 92.6% and has risen +7.6% in the last 30 days. For next year, the consensus is $3.78 (+21.8% YoY, +11.2% in the last month). Based on these revisions, Zacks ranks Newmont #2 Buy.

PulteGroup’s Trend: Earnings Revisions, Zacks Rank Boost PHM Near-Term Upside

December 12, 2025, 12:33 PM EST. PHM has drawn attention from Zacks readers as it navigates near-term volatility. Over the past month, PulteGroup shares are down about 6.8%, lagging the S&P 500’s 4.1% gain, as the Building Products – Home Builders group slides. The key driver for near-term moves remains earnings estimates revisions: stronger revisions tend to lift a stock’s fair value and, in turn, its price. For the current quarter, PHM is expected to post $3.20 per share (up ~6.7% year over year). The consensus annual EPS sits at $12.89, up about 10% from last year, with next year at $13.38, about 3.8% higher. Zacks assigns a Rank #2 (Buy) to PHM, reflecting a favorable blend of revision momentum and valuation in an improving housing backdrop.

GigaCloud Technology Inc. (GCT) in Focus as Earnings Revisions Drive Near-Term Moves

December 12, 2025, 12:32 PM EST. GigaCloud Technology Inc. has surged +47.8% over the last month as investors weigh the earnings outlook. In Zacks’ framework, near-term moves are driven by revisions to estimates. For the current quarter, GCT is expected to earn $0.67 per share, up +13.6% year over year; the full year is seen at $2.67 (+16.1%), and next year at $3.29 (+23%). Despite the price action, Zacks assigns a Rank #5 (Strong Sell) based on the scale of revisions and other factors. The focus remains on whether revenue growth can accompany rising earnings, as sustained top-line momentum supports fair value versus the market.

HEI Stock: Why HEICO’s Aerospace Play Deserves a Buy Now

December 12, 2025, 12:31 PM EST. HEI stock is positioned as a compelling aerospace play thanks to a Zacks Rank #2 (Buy) and robust growth prospects. The Zacks consensus projects 2025 EPS of $4.77 (+30%) and sales of $4.43B (+14.8%), with a long-term growth rate of 18.9% and a track record of beating estimates (avg surprise 13.35% over the last four quarters). Balance sheet strength shows debt-to-capital 36.8%, TIE 7.27, and a current ratio 3.35. Key catalysts include rising air travel driving aftermarket demand, ongoing defense spending, and disciplined acquisitions expanding the portfolio. YTD gain: 32.6% versus industry 31.7%. Peers: Astronics (Rank #1), Curtiss-Wright (Rank #2), and Woodward (Rank #2).

Lantronix Expands Drone and Defense Reach with Trillium NDAA/TAA Edge AI Deal

December 12, 2025, 12:30 PM EST. Lantronix, Inc. (LTRX) has struck a NDAA/TAA-compliant edge AI deal with Trillium Engineering, a major maker of gimbaled imaging systems for UAS. The collaboration broadens Lantronix’s footprint in the high-growth global drone market, projected to reach about $57.8 billion by 2030, and underscores its role in defense and intelligence tech. The partnership leverages Lantronix’s Open-Q 5165RB System on Module powered by Qualcomm DragonWing processors to enable on-device AI with real-time edge processing, adaptive object detection, and GPS-denied targeting in compact drones. Management says the win demonstrates scalable, recurring revenue potential across defense and commercial sectors, reinforcing Lantronix’s moat in IoT and AI. The deal complements a broader strategy to deliver compliant, high-margin Edge AI solutions for government programs.

Curtiss-Wright CW: Why It’s A Buy Now Amid Strong Growth & Solid Fundamentals

December 12, 2025, 12:29 PM EST. Curtiss-Wright (CW) remains a compelling pick in aerospace and defense. Zacks ranks CW #2 (Buy), citing strong growth momentum with 2025 EPS estimate of $13.09, up 20.1% year over year, and 2025 sales of $3.44 billion (+10.2%). Long-term earnings growth is pegged at 14.5%, with an average earnings surprise of 7.75% over the last four quarters. The stock benefits from a solid balance sheet: debt-to-capital of 27.7% vs. industry 49.4%, TIE of 14.92, and a current ratio of 1.75. The company is well-positioned in clean energy and defense, with AP1000-related tech and the Ultra Energy acquisition strengthening reactor protection and monitoring. Growth in Naval & Power and expanding aerospace demand support steady cash flow and shareholder returns. Peers include Astronics, Heico, and Woodward (Astronics #1).

GE Vernova (GEV) Stock: Investor Update Rally Drives Optimism, Valuation Debate Deepens

December 12, 2025, 12:28 PM EST. GE Vernova (NYSE: GEV) closed a volatile week after an investor update that lifted 2026-2028 targets and boosted capital returns, sparking a rally before a downgrade from Seaport Research Partners to Neutral/Hold cooled the mood. On Dec 11, shares closed near $704; Dec 12, they traded around $688 as the downgrade circulated. The move highlights a broader valuation debate: how much is baked in for a company positioned as a scarce ‘picks-and-shovels’ supplier to rising power demand. New targets: 2025 revenue $36-$37B, Adj. EBITDA margin 8%-9%, FCF $3.5-$4.0B; 2026 revenue $41-$42B, margin 11%-13%, FCF $4.5-$5.0B; 2028 revenue $52B, margin 20%, cumulative FCF > $22B. Backlog target lifts toward $200B by 2028.

Roper Technologies Sees Momentum in Technology Enabled Products; 2025 Revenue Outlook Improves

December 12, 2025, 12:27 PM EST. Roper Technologies (ROP) shows continued momentum in its Technology Enabled Products segment, led by medical devices and related software. In Q3 2025, the segment’s organic revenues rose about 6% YoY, driven by strengths in ultrasonic meters, Neptune’s cloud-based data and billing software, and solid Verathon performance (BFlex & GlideScope). NDI benefited from demand for cardiac, neurology and orthopedic precision measurement. ROP also notes strong traction in its Application Software (Deltek, Vertafore, PowerPlan, Aderant) and Network Software units, supporting an expected total revenue rise of about 12.9% in 2025 and 6% organic growth for the year. Near-term outlook for Q4 2025: segment organic growth in the low-single digits. Valuation remains attractive versus peers (forward P/E ~20.9x vs industry ~25.3x); Zacks Rank #3 (Hold).

AI stocks slip as Broadcom leads tech weakness while broader market rides rotation

December 12, 2025, 12:24 PM EST. AI stocks slipped again on Friday, with Broadcom dropping 7.7% after solid AI-related results but cautious guidance. Oracle tumbled nearly 11% amid questions about the ROI of AI spending. Yet the broader market remained resilient: the S&P 500 nursed a fractional decline, the Dow rose roughly 0.2%, and the Nasdaq dipped about 0.2%. Smaller stocks outperformed, with the Russell 2000 up about 2.8% for the week, while Visa helped lift the blue-chip index. Investors grew more confident on rates after the Fed cut rates for the third time this year, with expectations of further easing in 2026. The pullback in AI names follows a period of outsized gains, illustrating a rotation where non-tech and value plays help buoy Wall Street.

Oxford Nanopore CFO Nick Keher acquires 118 SIP partnership shares with 118 matching shares

December 12, 2025, 12:23 PM EST. Oxford Nanopore Technologies plc disclosed that Nick Keher, the Chief Financial Officer and a PDMR, participated in the company’s Share Incentive Plan (SIP). On 12 December 2025, the SIP Trustee purchased 118 Partnership Shares for Keher at £1.27 per share. Under the SIP, one Matching Share is awarded for each Partnership Share, and on the same date the Company issued a further 118 Ordinary Shares to the SIP Trustee to satisfy the Matching Shares. Details filed under MAR show instrument-Ordinary shares (GB00BP6S8Z30); aggregate price £149.86; venue-London Stock Exchange. This is an initial notification by Keher and associated disclosures by the SIP Trustee.

Notice of Delisting: AQUEDUCT EUROPEAN CLO 8 DAC on Euronext Dublin (85668)

December 12, 2025, 12:22 PM EST. Euronext Dublin has issued a notice of delisting for the vehicle AQUEDUCT EUROPEAN CLO 8 DAC. The action indicates that the security will be removed from trading on the exchange and investors should consult the delisting notice for the exact dates, withdrawal procedures, and any post-delisting considerations. Market participants should assess liquidity implications, potential wind-down terms, and any exit options as outlined by the exchange or issuer. This announcement underscores the exchange’s delisting process and serves as a reminder to review regulatory filings and notices for procedural details, deadlines, and any required actions to finalize holdings or transfers.

Cattle Futures Rally on Cash Strength Ahead of Friday Trade

December 12, 2025, 12:21 PM EST. Live cattle futures closed higher Thursday as the cash beef market strengthened, with nearby contracts up $2.30 to $3.57. Cash trade logged about $230 per cwt nationally. Feeder cattle futures rose $4.60 to $5.02 in the nearbys, while the CME Feeder Cattle Index ticked up to 345.47 on December 10. Export sales for 2025 and 2026 were modest (3,863 MT and 2,922 MT respectively) and shipments reached a 15-week high at 13,907 MT. Boxed beef prices eased, with Choice at 358.11 and Select at 343.46. Slaughter totals were about 484,000 for the week so far, with Thursday at 123,000. The data keep investors eyeing Friday’s session.

Wheat Faces Friday AM Weakness as December Futures Expire

December 12, 2025, 12:20 PM EST. Wheat prices are slipping in early Friday trade after a mostly mixed session on Thursday, with December futures set to expire later today. The session saw the hard red contracts as the weak link, while CH SRW posted modest gains on Thursday; OI rose by about 4,000 contracts, signaling ongoing investor interest. Front-month KC HRW faded slightly, with MPLS spring wheat inching higher in the near term. USDA’s Export Sales data for the week ending 11/13 showed 850,418 MT sold, a six-week high and up about 55% from a year ago, helping push accumulated wheat commitments to 18.12 MMT, the strongest weekly total since 2013/14. Global data showed September shipments at 3.23 MMT (118.68 mbu), the largest for the month in 12 years. Private buyers including a South Korean importer bought 65,000 MT.

Cotton Starts Friday Higher as Export Sales Fall; Oil Dips, Dollar Slips

December 12, 2025, 12:19 PM EST. Cotton futures are higher on Friday morning, up 5 to 22 points after a light Thursday pullback that left contracts down 8 to 12 points at the close. Crude oil futures are down 54 cents to $57.92, while the U.S. dollar index trades lower by about 0.373 to 98.395. The latest Export Sales data (week of 11/13) show cotton bookings of 187,648 RB, down from last year, with shipments at 113,219 RB-the second-lowest of the marketing year. September cotton exports (excluding linters) total 592,176 bales, up 17.16% year over year but down 7.88% from August. The Cotlook A Index rose 25 points to 73.95 cents, and ICE certified stocks were steady at 13,971 bales. The Adjusted World Price is 50.39 cents per pound, down 89 points from the prior week.

Repay RPAY Options Traders Bet on a Big Move as IV Surges

December 12, 2025, 12:18 PM EST. Repay Holdings Corp. (RPAY) is drawing attention in the options market as the Dec 19, 2025 $2.50 Call shows some of the highest Implied Volatility among equity options today. Implied Volatility signals the market expects a big move in the stock by expiry, potentially a rally or a sharp sell-off. Yet the fundamental picture is softer: Zacks ranks RPAY #4 Sell in Financial Transaction Services, and the quarterly consensus has slipped from 23 cents to 22 cents per share over the last two months. Many traders may try to sell premium when IV is rich to profit from time decay. Investors should weigh near-term catalysts and the gap between elevated option prices and the relatively weak fundamentals before trading.

Fortinet Options Market Signals a Potential Big Move

December 12, 2025, 12:17 PM EST. Fortinet (FTNT) has the market’s attention as the Jan 16, 2026 $25 call features unusually high implied volatility, signaling traders expect a big move. High IV can reflect a potential rally or a sharp drop, or an upcoming event, but it is only part of the story. Fundamentally, Fortinet carries a Zacks Rank of #3 (Hold) in the Security group, with 60-day earnings estimates rising from 66 cents to 74 cents. Many options traders look to sell premium when volatility is elevated, aiming for decay if the stock’s move is smaller than expected. The piece also notes analyst activity and a broader set of trade ideas from Zacks, underscoring that investors should weigh the IV signal against the earnings trajectory for FTNT.

e.l.f. Beauty Tumbles in 2025: What 2026 Holds for ELF Stock

December 12, 2025, 12:16 PM EST. e.l.f. Beauty (ELF) has fallen sharply in 2025 as organic growth slows and margins face sustained tariff headwinds. Production relies heavily on China, lifting tariff-driven costs and squeezing gross margin, even as retailers delayed a price increase. The company also carries higher SG&A and investments in ERP, international infra and staff, weighing on EBITDA and cash flow. The Rhode acquisition has boosted debt, raising financial risk amid a fragile margin backdrop. Analysts have cut EPS estimates for fiscal 2026/2027 on slower top-line growth. The stock trades at a modest forward P/E (about 22x) versus peers, but the case depends on margin recovery and stronger international growth. For 2026, monitor tariff relief, cost discipline, and whether price hikes translate to real profit.

Bank of America Reiterates Buy on NVDA, Sees Leadership in AI Compute with $275 Target

December 12, 2025, 12:13 PM EST. Bank of America reiterates a Buy rating on NVIDIA (NVDA) with a $275 target, citing the company’s leading share in AI compute and networking markets. The note, dated December 10, highlights NVDA’s valuation as justified by a 28x CY27E PE ex cash within its historical 25x-56x forward range, tempered by AI project lumpiness, cyclicality in gaming, and potential power access concerns. The stock has gained attention after reports the US may allow Nvidia to sell its H200 AI chips to China under a revenue-sharing framework designed to curb China’s chip-scale ambitions. Street consensus remains Buy, with a current average target of around $250 (upside to ~36%), and a Street-high of $432. NVIDIA remains focused on AI-driven data centers, autonomous vehicles, robotics, and cloud services, even as some investors seek higher upside and lower downside risk.

Implied Volatility Surges in ALNY Options Ahead of Key Date

December 12, 2025, 12:12 PM EST. Implied Volatility is surging for Alnylam Pharmaceuticals (ALNY) options, with the Dec 19, 2025 $75 Call showing some of the highest implied volatility among equity options today. Implied volatility reflects the market’s expected price swing, signaling a potential big move or upcoming event for the stock. Despite the IV spike, ALNY sports a Zacks Rank #3 (Hold) in the Medical – Biomedical and Genetics group, after analysts raised the current-quarter earnings estimate from $1.36 to $1.51. Some options traders may seek to sell premium on high-IV bets, aiming to profit from time decay if the stock doesn’t move as much as anticipated. Investors should weigh the fundamentals against the options signal and monitor any near-term catalysts.

A $1,000 Lam Research Investment from 10 Years Ago: What It Would Be Worth Today

December 12, 2025, 12:11 PM EST. This analysis traces what a $1,000 investment in Lam Research (LRCX) from a decade ago would be worth today. Lam Research, headquartered in Fremont, CA, supplies wafer fabrication equipment and services to the semiconductor industry, with strengths in deposition and etch that improve yields and reduce costs. It serves three market segments – Memory, Foundry and Logic/Other – and posted about $14.9B in revenue in fiscal 2024, split across leading-edge equipment sales and the Reliant after-market business. Geographically, revenue leans toward China and Asia, with contributions from Korea, Taiwan and Japan. The piece discusses business drivers, competitive dynamics with Hitachi, Tokyo Electron and Applied Materials, and semiconductor cycle exposure to explain why a $1,000 outcome depends on timing, yet Lam’s scale supports meaningful long-term upside.

Here’s How Much a $1,000 Investment in Newmont Corporation Would Be Worth Today (10 Years On)

December 12, 2025, 12:09 PM EST. Long-run investors in Newmont (NEM) would have seen a steady expansion of value from a decade ago, driven by its status as one of the world’s largest gold producers and a diversified asset base. If you invested $1,000 ten years ago, your position would reflect Newmont’s strategic growth, including the acquisitions of Goldcorp in 2019 and Newcrest Mining in 2023, which broadened its portfolio across multiple continents. The company has operated mines across North America, South America, Australia and Africa, with notable reserves and production that support a robust balance sheet. Beyond M&A activity, recent asset-sales and portfolio optimization shaped its financial flexibility. Overall, patient investors in Newmont could have ridden a long-term uptrend in a sector-wide rally for gold.

What $1,000 Invested in Harmony Gold a Decade Ago Would Be Worth Today: A Long-Term Perspective

December 12, 2025, 12:08 PM EST. Looking back over a decade, this piece uses Harmony Gold (HMY) to illustrate how stock-price movements and emotions like FOMO shape portfolio results. Harmony Gold Mining Company Limited, based in Randfontein, is South Africa’s largest gold producer by volume, with 2023 output around 1.47 million ounces. Its operations span nine underground mines domestically and several surface facilities, plus Hidden Valley in Papua New Guinea and a 50% stake in the Wafi-Golpu project. The company has pursued growth through acquisitions, including the Eva Copper project. Beyond price, the article highlights long-term drivers–production mix, geographic exposure, and exploration prospects-as essential context for what a decade of holding might imply for returns.

Is the iHeartMedia Options Market Signaling a Spike in IHRT?

December 12, 2025, 12:07 PM EST. Investors watching IHRT should note that the Dec 19, 2025 $7.50 Put shows unusually high implied volatility, signaling expectations of a big move. Implied volatility reflects anticipated near-term movement and can rise on events or catalysts. Despite the price action, iHeartMedia remains a Zacks Rank #3 (Hold) in the Broadcast Radio/Television group, with analysts lowering earnings estimates for the current quarter. The combo of elevated IV and modest fundamentals could point to a setup where options traders sell premium to capture time decay, rather than bet on a directional move. As always, IV is only one piece of the puzzle; traders should weigh earnings timing, catalysts, and risk management before acting.

Royal Caribbean (RCL) Surges 7.4% on Dividend Boost and Buyback; Eyes Q Earnings

December 12, 2025, 12:06 PM EST. Royal Caribbean RCL jumped 7.4% to $279.7 as higher volume accompanied news of a $1.00 quarterly dividend payable Jan. 14, 2026 and a $2 billion stock buyback program. The cruise operator also offered upbeat near-term expectations, with consensus EPS projected at $2.80 for the upcoming quarter, up about 71.8% year over year, and revenues seen at $4.27 billion, up 13.4%. Analysts note that revisions to earnings estimates have been marginally positive, a factor often linked to price gains. Zacks still lists RCL as a Hold (Rank #3). In the same space, Carnival (CCL) rose 5.9% to $27.84, though its own EPS outlook has shifted, with the consensus up 78.6% year over year. Investors will watch whether momentum persists into the next report.

Netflix NFLX Stock News Today: Warner Bros. Deal Drama, Paramount Challenge, Analyst Forecasts, and Key Levels (Dec 12, 2025)

December 12, 2025, 12:05 PM EST. Netflix shares face a crossroads as the market weighs the proposed Warner Bros. Discovery asset deal against a rising Paramount Skydance hostile bid. The transaction targets roughly $72 billion equity value and $82.7 billion EV, with a meaningful debt load and ongoing regulatory risk that could shape outcomes. Analysts have begun updating targets for NFLX amid deal momentum and potential debt implications, while traders monitor the stock on a split-adjusted basis after the 10-for-1 split. If Netflix presses ahead, questions center on $2-$3 billion of annual cost savings by year three and how the combined platform would affect margins and content leverage. Stay tuned for headlines, forecasts, and critical price levels on Dec 12, 2025.

Next-Era Covered-Call ETFs Pay Up to 89% Yield: RDVI and Peers in Focus

December 12, 2025, 12:03 PM EST. Covered-call strategies generate income in rising, falling or sideways markets by selling calls against stocks you own, keeping the premium and risking being called away. The piece surveys a four-pack of new-age funds promising yields of 7%, 12% and even 89%. It kicks off with FT Vest’s RDVI, which yields about 8.2% and layers covered calls atop Nasdaq Rising Dividend Achievers. RDVI sells calls against the S&P 500 rather than its own index, aiming for income but offering limited diversification. The article notes RDVI is a young strategy, may underperform its underlying index, and raises questions about whether it offers meaningful differentiation from peers.

Micron MU Q1 2026 Earnings Preview: AI Demand Boosts Revenue Amid Improving Memory Pricing

December 12, 2025, 12:02 PM EST. Micron Technology (MU) is set to report fiscal Q1 2026 results after the close on Dec. 17. The company guides Q1 revenue of about $12.5 billion and adjusted EPS of roughly $3.75, vs. a Zacks consensus of $12.57 billion and $3.83 per share. The earnings ESP stands at +5.97%, and MU carries a Zacks Rank #1, signaling a likely beat. Key drivers include AI-driven demand for memory in data-center GPUs, with DRAM expected to reach about $10.13 billion in the quarter, up ~58% YoY. Improved supply-demand dynamics and industry discipline have supported memory pricing and chip mix, including next-gen DRAM, HBM3E, and NAND ramps. If macro headwinds stay contained, MU could extend gains as AI adoption sustains memory demand.

Rivian Autonomy & AI Day: In-House Chips, LiDAR Push, and Stock Implications

December 12, 2025, 12:01 PM EST. Rivian used Autonomy & AI Day to outline a sharper in-house tech strategy for its EVs. The centerpiece is the Rivian Autonomy Processor (RAP1), powering the Gen 3 Autonomy Computer and targeting heavy AI and vision workloads with 205 GB/s bandwidth, aiming to cut supply-chain risk from NVIDIA/Qualcomm. The event also introduced an AI-powered Rivian Assistant and a near-term Universal Hands-Free update covering over 3.5 million miles of North America roads. Rivian plans LiDAR-driven Level 4 capability, aided by new custom chips and an upgraded autonomy stack. An Autonomy+ subscription debuts at $2,500 upfront or $49.99/month, cheaper than Tesla’s option. With R2 and VW partnership on the horizon, the stock’s YTD +24% rise contrasts with a ~79% drop from IPO, amid demand softness and price pressure.

2 AI Nuclear Energy Stocks to Buy Now Before They Soar: GEV, CEG, and NextEra

December 12, 2025, 12:00 PM EST. GE Vernova (GEV) has surged on AI-boosted guidance, doubling its dividend and lifting buybacks, underscoring how AI demand is shaping energy stocks. This piece spotlights two top AI-energy names: Constellation Energy (CEG) and NextEra Energy, arguing that GEV’s breakout signals where investors may look next. With GEV up roughly 400% since its April 2024 IPO, analysts say AI-driven power expansion- fueled by data centers, hyperscalers, and government grid initiatives-could lift the broader sector. The narrative highlights the electricity demand surge from AI and the need for stronger grids and nuclear/clean energy. Owning nuclear-energy-focused players like CEG and NextEra could capture AI-led growth via long-term contracts and grid investments that support durable returns.

BigBear.ai (BBAI) vs. SoundHound AI (SOUN): Which AI Stock Is the Better Buy Now?

December 12, 2025, 11:59 AM EST. AI investing has expanded beyond mega-cap names to niche players like BigBear.ai and SoundHound AI. BigBear.ai anchors itself in defense and government markets, offering secure, mission-critical decision intelligence, while SoundHound targets commercial AI in voice and customer experience. In Q3 2025, BigBear.ai posted a 20% revenue dip to $33.1M, gross margin fell to 22.4%, and adjusted EBITDA showed a loss as SG&A funded growth. Yet the balance sheet strengthened with a record $456.6M cash and the strategic Ask Sage acquisition, expected to add about $25M ARR in 2025. By contrast, SoundHound posted stronger top-line momentum. The choice hinges on risk tolerance: regulated government contracts vs commercial AI scale, execution, and valuation.

Agnico Eagle Eyes Further Shareholder Returns on Strong Free Cash Flow

December 12, 2025, 11:58 AM EST. Agnico Eagle Mines Limited (AEM) posted a Q3 free cash flow of about $1.2B and roughly $1.8B in operating cash flow, underpinning a $350M quarterly return and a nine-month total of about $900M to shareholders. The company notes potential to lift dividends and buybacks further while gold remains elevated and its balance sheet stays solid. In 2024, it returned roughly 43% of free cash flow to shareholders. Relative to peers, Barrick and Newmont also reward holders with sizable programs. However, AEM trades at a forward P/E of about 18.2x vs. an industry average near 13.3x, underscoring a premium for the growth cadence. With the positive gold price backdrop and strong cash generation, AEM could sustain a shareholder-focused return trajectory.

Home Depot Stock (HD) News: Investor Day Outlook, 2025 Guidance, and 2026 Setup

December 12, 2025, 11:57 AM EST. HD traded around $357.46, up ~1.8% after an Investor Day that reaffirmed fiscal 2025 guidance and outlined a cautious but constructive fiscal 2026 outlook. Management kept ~3% total sales growth and slightly positive comparable sales for 2025, with EPS to decline YoY. For 2026, the baseline assumes a flat-to-modest home-improvement market, with comps flat to +2%, total sales growth ~2.5%-4.5%, and operating margins ~12.4%-12.6% (adjusted ~12.8%-13.0%), with EPS flat to +4%. Analysts trimmed targets but largely kept ratings, signaling a reset rather than a broken story. The stock’s near-term move remains linked to housing turnover and big-ticket demand amid higher borrowing costs.

Fed Cuts Rates for Third Time; 4 Discretionary Stocks Set for Upside

December 12, 2025, 11:56 AM EST. Markets cheered as the Fed cut rates for the third time this year, lifting U.S. equities higher. The central bank signaled a dovish stance, with inflation seen easing toward 2.4% by 2026 and growth accelerating to 2.3%, boosting confidence in discretionary names. The piece highlights four consumer discretionary stocks with upside: Brightstar Lottery PLC (BRSL), Las Vegas Sands (LVS), Roku (ROKU) and Kontoor Brands (KTB). BRSL has projected earnings growth of about 17.9% this year with a Zacks Rank of #2; LVS carries a Strong Buy rating and an expected earnings rise around 30%; Roku remains a leading streaming platform with strong growth prospects; Kontoor Brands also shows solid prospects. Investors remain optimistic that the rate path supports consumer spending and the broader market in 2026.

Amgen’s Uplizna Receives FDA Nod for Generalized Myasthenia Gravis, Expands Rare-Disease Portfolio

December 12, 2025, 11:55 AM EST. Amgen AMGN won FDA approval to expand Uplizna (inebilizumab) into generalized myasthenia gravis (gMG) for adults positive to anti-AChR or anti-MuSK antibodies. As the first CD19-targeted B-cell therapy for this indication, Uplizna offers a twice-yearly dosing option compared with more frequent regimens. The decision is supported by phase III MINT data showing strong efficacy. This marks Uplizna’s second approval this year and third in the U.S., following a prior IgG4-related disease indication and an NMOSD label. The move strengthens Amgen’s rare-disease portfolio after acquiring Horizon Therapeutics. In a competitive gMG space, Uplizna faces Vyvgart/Vyvgart Hytrulo, Imaavy and Rystiggo, all FcRn blockers with varying age approvals.

CVX vs SU: 2026 Plans and Upside for Investors

December 12, 2025, 11:53 AM EST. Two integrated oil players, Chevron (CVX) and Suncor (SU), frame 2026 as a pivotal year. Chevron centers its plan on upstream catalysts, including Tengizchevroil expansion, Gulf of Mexico deepwater, and a Permian run rate of ~1 million boe/d, plus the Hess acquisition driving ~$1.5B in synergies. Management targets roughly $12.5B of annual free cash flow by 2026, aided by $3-$4B in structural cost cuts and disciplined capex, with annual share buybacks of $10-$20B depending on prices. Suncor emphasizes a low corporate decline rate and long-life oil sands value, delivering steady free cash flow and high utilization (refining ~101-102%). Its plan funds sustaining capex plus targeted investments (in situ pads, Fort Hills) and downstream optimization, underpinned by operational reliability.

Apple Stock (AAPL) Eyes Ninth Circuit App Store Ruling, Analyst Targets, and 2026 Outlook

December 12, 2025, 11:51 AM EST. Apple Stock (AAPL) climbs into the spotlight as the Ninth Circuit keeps pressure on the App Store in the Epic Games dispute, while sending the case back to determine a reasonable commission on external purchases. The ruling preserves a path to fees rather than a full ban, a win for the Apps/Services economics but with new constraints that could compress take rates over time. Apple’s stock hovered near $277-$278 on Dec 12, 2025, with a 52-week range of about $169 to $289 and a market cap around $4.1 trillion. Analysts have rolled out fresh price targets tied to demand for the iPhone 17 and Apple’s evolving AI push into 2026. The read-through is mixed: potential margin pressure on external payments vs greater clarity and a reined-in pricing dynamic for the App Store.

NYSE Pre-Market Update as Chipotle Rings Opening Bell Amid Expansion

December 12, 2025, 11:50 AM EST. Markets open mixed after a session where the Dow wavered while the S&P 500 and Russell 2000 posted record highs. A quarter-point rate cut by the Federal Reserve boosted growth expectations and encouraged a shift into cyclical stocks. In company news, Chipotle Mexican Grill (CMG) rose about 2.7% ahead of its announcement that it opened its 4,000th restaurant in Manhattan, Kansas, with CEO Scott Boatwright set to ring the NYSE opening bell to celebrate. The NYSE’s pre-market update also guides investors as they digest policy signals and ongoing expansion momentum. Traders will monitor today’s action for further moves driven by data and sentiment across equities and futures.

NYSE Pre-Market Update: Dow Mixed, Fed Cut Boosts Cyclicals as Chipotle Rings NYSE Bell for 4,000th Restaurant

December 12, 2025, 11:49 AM EST. New York, Dec. 12, 2025 – The Dow is mixed early Friday after a session where the S&P 500 and Russell 2000 posted record highs. A quarter-point rate cut by the Federal Reserve lowered borrowing costs and lifted growth forecasts for next year, supporting moves into cyclical stocks. Chipotle Mexican Grill (CMG) rose about 2.7%, ahead of today’s update announcing its 4,000th restaurant in Manhattan, Kansas. CEO Scott Boatwright will ring the NYSE opening bell to celebrate the milestone, underscoring expanding footprints while markets digest the pre-market read on sentiment.

Jim Cramer’s Top 10 Watch List for Friday: Tech Rotation, Earnings, and Key Moves

December 12, 2025, 11:47 AM EST. Markets saw a rotation out of tech into value as the Dow eyes another record and the Nasdaq stalls; S&P futures flat after a record close. The Club’s December monthly meeting streams at noon ET. Key stock moves: Lululemon (CEO McDonald to depart; earnings OK; upgrade to hold; stock up 10% premarket); Broadcom down ~5% on a misunderstood quarter despite solid results and higher guidance; chatter about customers moving chip work in-house; Costco beat on earnings but faces a global growth backdrop, with target trimmed; Linde named a top pick by Citi after a positive investor meeting; RH (Restoration Hardware) touts Paris store; EPS miss, revenue in line, targets cut; BMS upgraded by Guggenheim; Fermi plummets ~44% on tenant termination.

Which Of The Latest 13F Filers Hold Visa (V) – 17 Funds

December 12, 2025, 11:46 AM EST. At Holdings Channel, the latest batch of 13F filings for the 06/30/2024 period shows that Visa (Symbol: V) is held by 17 of the 32 funds reviewed. Remember that 13F filings reveal only long positions, not shorts, so the full picture may be more nuanced. In this batch, 6 funds increased their V positions, while 8 reduced theirs, with all 4,205 funds analyzed holding 347,761,184 shares at 06/30/2024 versus 352,732,288 at 03/31/2024 – a decline of about 1.41%. The aggregate change across funds shows -165,049 shares and -$81.9M in market value. The takeaway: aggregating 13F activity can reveal shifts in sentiment around Visa, even as hedging and other strategies may complicate the story.

FLI:CA Stock Analysis and AI Trading Signals – CI Lifeco Covered Call ETF Update

December 12, 2025, 11:43 AM EST. Market update on FLI:CA (CI U.S. & Canada Lifeco Covered Call ETF) with AI-generated signals. The latest December 12 update shows a mixed ratings framework: Near-term: Strong, Mid-term: Neutral, Long-term: Strong. The trading plan calls for a long entry near 11.72 with a stop at 11.66; no short positions are offered at this time. The report also notes to check the timestamp and that updates for AI-generated signals are available. Investors should weigh risk, monitor price action around the 11.7 area, and stay tuned for further AI insights on FLI:CA.

FRMI Stock Price Live: Fermi Inc. Plunges 39.80% Amid Sparse Analyst Coverage

December 12, 2025, 11:42 AM EST. Fermi Inc. (FRMI) is showing a sharp intraday slide, down -39.80% to -6.07, with a Candlestick chart across 1D and 5D timeframes. The stock has no earnings data available and 0 analyst ratings, with an Average Price Target: $0. Prominent in the accompanying content is Tim’s Millionaire Formula promotion, but there is currently limited fundamental data to justify valuation. The combination of no earnings data and no analyst coverage suggests caution for traders and potential investors.

Is First Capital REIT (TSX:FCR.UN) Undervalued After Its Share Consolidation? A DCF Valuation Snapshot

December 12, 2025, 11:41 AM EST. First Capital Real Estate Investment Trust (TSX:FCR.UN) has outperformed Canadian REIT peers over the past year, with a consolidation near the high CA$18 range. At about CA$18.70, it has posted a YTD return of 9.29% and a five-year total return of 61.80%, signaling persistent momentum. The stock trades at a P/E of 16.1x, clearly discounting peers (peer average ~32.1x; industry ~23.4x). Our SWS DCF model puts fair value at CA$24.80 per unit, implying roughly +24.6% upside. Risks include rate volatility and weaker leasing spreads that could compress multiples and trim the margin of safety. The question remains whether investors should chase further gains or lock in current upside.

Broadcom (AVGO) Emerges as Brasada’s Best YTD Pick Amid AI Momentum

December 12, 2025, 11:40 AM EST. Brasada Capital Management’s Q3 2025 letter spotlights Broadcom (AVGO) as its best year-to-date performer, noting an 18.66% one-month gain and a 52-week surge of about 80.77%. As of Dec 11, 2025, AVGO traded around $406.37 with a $1.919 trillion market cap. The firm added Broadcom to Equity Income in April, praising its mega-cap semiconductor profile, cash flow and dividend growth. Brasada says Broadcom is well positioned in the AI race alongside Nvidia and could be a top winner over the next decade. Despite AI upside elsewhere, the letter acknowledges Broadcom’s solid fundamentals – record Q3 revenue of $16B (+22% YoY) and extensive hedge fund ownership (183 portfolios). The market environment remained near all-time highs with potential policy easing, guiding selective investment and risk controls.

REG – Euronext Dublin: Notice to Noteholders (Twin Bridges 2022-2 PLC) [85661]

December 12, 2025, 11:39 AM EST. Regulatory notice to noteholders of Twin Bridges 2022-2 PLC on Euronext Dublin. The document directs investors to obtain SEC filings and other materials provided by Quartr, and notes data references from ICE Data Services and FactSet, with market data via TradingView. It outlines where to access investor documents, updates on payments and the terms of the securitised notes, and emphasizes compliance obligations for noteholders. This notification serves as the official channel for ongoing investor communications and regulatory disclosures.

One Health Group PLC exercises warrants; AIM admission increases voting rights to 13,831,833

December 12, 2025, 11:38 AM EST. One Health Group plc (AIM: OHGR) has received a notice to exercise 100,333 warrants at 150p per share, raising £150,499.50. The resulting Warrant Shares will be admitted to trading on AIM, with admission expected around 18 December 2025 at 8:00 a.m. These shares will be fully paid and rank pari passu with existing ordinary shares. Post-admission, the Total Voting Rights will be 13,831,833 shares; the company holds no treasury shares. The denominator is provided for Disclosure and Transparency Rules calculations. For investors, the update confirms potential dilution and the updated voting base following the new issue.

Progressive (PGR) Valuation Revisited: Short-Term Reset, Long-Term Momentum Persists

December 12, 2025, 11:37 AM EST. Progressive (PGR) has outpaced the market this month, with a near-term 4.8% gain, but 1-year TSR remains slightly negative. The data suggests a short-term price reset rather than a trend change, while a robust 3-year TSR above 80% signals durable momentum. The stock trades at roughly 12.6x P/E versus a 12x fair value, and a fair value estimate of $257.44 implies the shares are undervalued today given improving underwriting efficiency from analytics, telematics, and model enhancements. However, risks include higher claim costs and tougher competition that could pressure margins and premium growth. A potential valuation gap exists versus peers and the broader industry, prompting investors to weigh the upside against near-term headwinds.

IPCO Insider Buys Lead to 243% Holdings Jump as CEO Lundin Drives Purchase

December 12, 2025, 11:36 AM EST. Insiders were net buyers of International Petroleum Corporation (TSX: IPCO) stock over the past year. The biggest insider purchase was by CEO, President & Director William A. Lundin for CA$40m worth of shares at CA$20.94 per share, below the recent price of CA$25.73. Lundin bought a total of 1.91m shares at an average of CA$20.92. Overall insiders own about CA$174m of stock, roughly 5.8% of the company. There haven’t been insider transactions in the last three months, but the past year is encouraging and suggests insiders are aligned with shareholders. The article also flags two warning signs IPCO investors should know about, underscoring that insider activity is not a guaranteed signal.

Agilent Technologies (A): Valuation Check After Earnings Beat, Upgrades, and a Pullback

December 12, 2025, 11:35 AM EST. Agilent Technologies (A) posted a quarter ahead of expectations, prompting fresh Buy calls from Wall Street, yet the stock has slipped to around $142.87. The stock shows a 90-day return of about 16% and a five-year total shareholder return above 24%, signaling ongoing momentum despite a near-term pullback. While analysts’ price targets imply meaningful upside to around $167.57, a DCF model in the narrative suggests the stock could be overvalued with a fair value near $114.67. Key risks include rising tariffs and funding pressures in academia/government labs. The contrast highlights a potential valuation gap: strong revenue growth and margins support upside, but cash-flow assumptions may cap long-run returns.

Is J&J’s 45.8% Rally Justified by Its Cash Flow and Earnings Outlook?

December 12, 2025, 11:34 AM EST. Johnson & Johnson has surged 45.8% year-to-date, with a run that reflects renewed confidence in its long-term cash generation and product momentum. The stock’s move comes as pipeline updates in immunology and oncology align with a more favorable risk/reward outlook, even as policy headlines remain a factor. On the valuation framework, J&J earns a 4/6 score, indicating it is undervalued on multiple metrics. A DCF analysis points to an intrinsic value around $384 per share, implying about a 45% discount to the current price and suggesting the market may be pricing conservatively relative to long-term cash flow potential. The company generated about $19.5B in free cash flow in the last twelve months, with forecasts rising to roughly $23-25B by 2028 and about $33B by 2029, underscoring a mature yet growing healthcare franchise.

EPD’s Inflation-Protected Contracts: Stable Cash Flows, Growth Catalysts

December 12, 2025, 11:33 AM EST. EPD’s business model features inflation-protected contracts, with nearly 90% of long-term agreements including fee adjustments in inflationary cycles, helping to safeguard cash flows. Its 50,000-mile pipeline network and over 300 million barrels of storage underpin sizable, stable cash generation. The company also expects incremental cash flows from roughly $5.1 billion in capital projects (Bahia pipeline, Fractionator 14, among others) that are already in service or nearing completion, potentially boosting income for investors. Peers KMI and ENB share similarly predictable, fee-based earnings. In recent pricing, EPD has risen about 7.2% year over year, versus a -5.6% industry trough. On valuation, EV/EBITDA sits at 10.52x vs. industry 10.56x. Zacks awards a Rank #3 Hold; earnings estimates have recently seen downward revisions.

EPD’s Inflation-Protected Contracts Offer Steady Cash Flows and Growth Catalysts

December 12, 2025, 11:32 AM EST. Enterprise Products Partners (EPD) stands out in midstream for an inflation-protected model, with roughly 90% of its long-term contracts able to raise fees in an inflationary environment, shielding cash flows. The network spans 50,000+ miles of pipelines and more than 300 million barrels of liquid storage, underpinning stable cash generation. EPD also expects incremental cash flows from its $5.1B backlog of capital projects, including the Bahia pipeline and Fractionator 14, as they come online. On valuation, EPD trades at an EV/EBITDA of 10.52x, just below the industry average of about 10.56x. The stock has risen about 7.2% over the last year. Zacks currently rates it Hold amid downward earnings revisions for 2025. For income-focused investors, EPD’s inflation-linked contracts and backlog-driven growth merit consideration.

EPD’s Inflation-Protected Contracts: Stable Cash Flows and Growth Upside

December 12, 2025, 11:31 AM EST. EPD, a midstream powerhouse, operates a pipeline network exceeding 50,000 miles and holds 300 million barrels of liquid storage, underpinning stable cash flows. The key edge is an inflation-protected business model: about 90% of long-term contracts include fee escalators to offset inflation, safeguarding cash generation across cycles. The growth trajectory rests on $5.1 billion of backlogged capital projects, including the Bahia pipeline and Fractionator 14, expected to lift incremental cash flows as they come online. For income-seekers, EPD looks appealing given its defensible earnings and backlog-driven upside. Relative to peers, EPD traded at an EV/EBITDA of about 10.5x versus the industry, with a modest valuation gap and a #3 Hold Zacks rank. Alongside KMI and ENB, midstream cash flows remain predictable and resilient.

5 Low-Leverage Stocks to Bet On as Investors Shy Away From Technology

December 12, 2025, 11:30 AM EST. Investors shrugged off tech shares as rates fell, sending major indices toward record closes. The piece argues that safer bets lie in low-leverage names and explains why a smaller debt-to-equity load can boost solvency during volatility. Highlighted picks include Casey’s General Stores (CASY), Hamilton Insurance Group (HG), Northrim Bancorp (NRIM), REV Group (REVG) and Engie (ENGIY). With debt financing a key risk, these firms may offer steadier cash flows and more resilient earnings in a rate-cut environment. The article also notes that AI hype keeps valuations lofty in tech, prompting investors to favor traditional, cash-flow-positive businesses and a prudent balance sheet as a hedge against downturns.

EPD’s Inflation-Protected Contracts: Stable Cash Flows and Upside from Capex

December 12, 2025, 11:29 AM EST. Enterprise Products Partners (EPD) stands out with a vast, 50,000+ mile pipeline network and 300 million barrels of storage, delivering stable, fee-based cash flows. About 90% of its long-term contracts feature inflation-adjustment provisions, making cash generation more resilient in inflationary environments. The company also expects incremental cash flows from roughly $5.1 billion in capex projects, including Bahia pipeline and Fractionator 14, enhancing upside for income-focused investors. Compared to midstream peers like KMI and ENB, EPD offers predictable, fee-based earnings. EPD’s stock has risen ~7.2% over the past year; EV/EBITDA is about 10.52x vs industry ~10.56x. Zacks reports a 2025 earnings estimate downward revision and a Zacks Rank #3 Hold. Overall, inflation-protected contracts and project backlogs support a potentially attractive, stable income thesis.

PhenixFIN Surpasses Q4 Earnings Estimates; EPS $0.90 Beats on $5.68M Revenue

December 12, 2025, 11:28 AM EST. PhenixFIN (PFX) reported Q4 earnings of $0.90 per share, topping the Zacks consensus of $0.78 and marking a 15.38% surprise vs. prior quarter’s $0.58. Year-ago earnings were $0.82. Revenue came in at $5.68 million, beating the consensus by 13.56% and up from $5.10 million a year earlier. The stock has risen about 23.2% year-to-date vs. the S&P 500 at 23.6%. Ahead, the moderate outlook remains driven by management commentary on the earnings call, with current-quarter estimates at $0.85 on $5.15 million and fiscal year expectations of $3.46 on $20.62 million. Zacks ranks PhenixFIN Hold (3); industry peers in Financial – SBIC & Commercial space currently rank in the top 8% of the sector.

PhenixFIN (PFX) Q4 Earnings Beat Estimates: EPS $0.90, Revenue $5.68M; Zacks Rank Hold

December 12, 2025, 11:27 AM EST. PhenixFIN (PFX) reported Q4 earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.78 for a 15.38% surprise. A quarter ago, it posted $0.58 vs $0.78 expected (−25.64%). Over the last four quarters, the firm has exceeded estimates three times. Q4 revenue was $5.68 million, ahead of the consensus by 13.56% and up from $5.1 million year ago. The stock has risen about 23.2% year-to-date, roughly matching the S&P 500. Looking forward, the current-quarter EPS estimate is $0.85 on $5.15 million in revenue, and the current fiscal year is seen at $3.46 on $20.62 million. Zacks assigns a #3 (Hold) rating; the industry is in the top 8% of Financial – SBIC & Commercial.

3 TSX Growth Stocks With Up To 22% Insider Ownership

December 12, 2025, 11:26 AM EST. As the TSX climbs, insider ownership signals confidence in growth names. This snapshot focuses on Canadian stocks with meaningful insider stakes, such as Stingray Group (RAY.A) at 22.9% with earnings growth of 33.9%, and Aritzia (ATZ) at 17.2% with a projected earnings rise of 19.4%. Other screen-listed names like Zedcor (ZDC) and West Red Lake Gold Mines (WRLG) show insider stakes in the low- to mid-teens and multiple growth metrics. The takeaway: higher insider ownership can align management and shareholders and accompany robust growth forecasts, but investors should weigh sector risk, volatility, and execution as markets advance.

PhenixFIN (PFX) Q4 Earnings Beat Estimates; EPS $0.90, Revenue $5.68M

December 12, 2025, 11:25 AM EST. PhenixFIN (PFX) reported Q4 earnings of $0.90 per share, ahead of the Zacks consensus of $0.78 and up from $0.82 a year ago. The result is adjusted for non-recurring items and reflects a 15.38% earnings surprise. Revenue came in at $5.68 million, beating estimates by 13.56% and above the year-ago $5.1 million. In the last four quarters, the company has topped consensus EPS three times and revenue three times. The stock has risen about 23.2% year-to-date, roughly matching the S&P 500 gain of 23.6%. Looking ahead, the near-term path hinges on the earnings outlook and revisions; PhenixFIN holds a Zacks Rank #3 (Hold).

PhenixFIN (PFX) Q4 Earnings Beat Estimates: EPS $0.90, Revenue $5.68M; Zacks Rank Holds

December 12, 2025, 11:24 AM EST. PhenixFIN (PFX) reported Q4 results beating expectations, with EPS of $0.90, up from $0.82 a year ago and ahead of the Zacks Consensus of $0.78, a 15.38% surprise. Revenue came in at $5.68 million, topping the consensus by about 13.6% versus $5.10 million a year earlier. Over the last four quarters, the company has topped estimates three times. The stock has risen roughly 23.2% year-to-date, in line with the S&P 500’s 23.6% gain. Ahead of the call, the Zacks Rank stands at #3 (Hold), with next-quarter consensus at $0.85 on $5.15 million and the full-year view at $3.46 on $20.62 million. Investors will be watching management commentary for near-term revisions and guidance.

Hologic’s US Diagnostics Strength: Panther Fusion, Vaginitis Tests, and Key Approvals

December 12, 2025, 11:23 AM EST. Hologic (HOLX) is leveraging a robust US Diagnostics runway, backed by a projected 9.12% CAGR in the US market through 2025-2030. In Q4 fiscal 2025, Diagnostics revenue rose 1.5% CC, with core US molecular diagnostics driving growth. Excluding COVID-19, organic Diagnostics sales jumped 4.4% CC, led by the Molecular Diagnostics unit and the BV, CV/TV vaginitis assays. The BV, CV/TV run rate addresses a large unmet need-over 20 million US women experience vaginitis annually, with under 40% tested. The Panther Fusion sidecar remains a key growth engine via workflow efficiency, offering >23 assays on an open-access platform. Recent milestones include the Genius Digital Diagnostics System CE expansion and FDA 510(k)/CE approvals for GI Bacterial assays, supporting further market share gains.

Hologic’s US Diagnostics Momentum Poised for Share Gain

December 12, 2025, 11:22 AM EST. Hologic (HOLX) is leveraging a resilient US Diagnostics franchise to sustain growth despite macro headwinds. In Q4 fiscal 2025, Diagnostics revenue rose 1.5% in constant currency, helped by stronger core U.S. molecular diagnostics; excluding COVID-19, organic Diagnostics sales were up 4.4% CC. The Molecular Diagnostics unit remains the growth engine, led by higher BV, CV/TV and Panther Fusion assays. The BV/CV vaginitis test targets a large unmet need (20M+ U.S. women with vaginitis annually, many untested). Management also highlights the Panther Fusion sidecar for broader workflow efficiency across 23+ assays with open-access testing. New Genius Digital Diagnostics System CE expansion and FDA/CE approvals for GI Bacterial assays should further bolster Hologic’s position in a US market projected to grow at ~9% CAGR through 2025-2030.

Hologic Gains Momentum in US Diagnostics on Molecular Growth and Panther Fusion

December 12, 2025, 11:21 AM EST. Hologic HOLX is capitalizing on a high-growth US Diagnostics market, benefiting from the Molecular Diagnostics push and the Panther Fusion sidecar. With the US market expected to grow at about 9.12% CAGR through 2025-2030, the company posted +1.5% CC Diagnostics revenue in Q4 FY2025, and +4.4% CC ex-COVID as core molecular tests strengthen. Growth drivers include the BV, CV/TV vaginitis assay in a large underserved market (20+ million US cases, with

Hologic Poised for Growth in US Diagnostics as Molecular Platform Gains Momentum

December 12, 2025, 11:20 AM EST. Hologic HOLX is leveraging a structurally sound US Diagnostics franchise to sustain growth, even as macro headwinds weigh on external markets. In Q4 FY2025, Diagnostics revenue rose 1.5% in constant currency, led by higher core U.S. molecular diagnostics sales; ex-COVID, organic diagnostics rose 4.4% CC. The Molecular Diagnostics unit remains the growth engine, boosted by BV, CV/TV vaginitis assays and Panther Fusion. The 2019-approved BV/CV vaginitis test addresses a large testing gap among >20 million women affected annually. Management also stresses the Panther Fusion sidecar for future growth, with its open-access PCR platform running 23+ assays and consolidating workflows. Recent milestones-Genius Digital Diagnostics System CE expansion and approvals for GI bacterial assays on Panther Fusion-are likely to extend HOLX’s market share in a US market that faces a CAGR ~9.12% through 2030.

5 Low-Leverage Stocks to Watch as Investors Seek Stability Over Tech

December 12, 2025, 11:17 AM EST. Amid a rate-cut backdrop, investors are gravitating toward low-leverage stocks over high-growth tech. The piece explains why debt virtually limits risk and highlights the debt-to-equity ratio as a key gauge of solvency. It suggests focusing on firms with modest leverage to weather market volatility and verify solid earnings growth. The list of example names includes Casey’s General Stores (CASY), Hamilton Insurance Group (HG), Northrim Bancorp (NRIM), REV Group (REVG) and Engie (ENGIY), securities that offer safer exposure during uncertain times. By prioritizing low leverage, solvency metrics, and stable cash flows, investors may achieve steadier returns when the market shuns tech stocks.

5 Low-Leverage Stocks to Bet On as Investors Shy Away From Tech

December 12, 2025, 11:16 AM EST. With U.S. indices closing higher after a December rate cut, investors shift from high-growth tech to low-leverage stocks and rate-sensitive plays. This piece spotlights five names-Casey’s General Stores (CASY), Hamilton Insurance Group (HG), Northrim Bancorp (NRIM), REV Group (REVG), and Engie (ENGIY)-chosen for lighter debt loads and stronger solvency. It explains leverage as debt financing and why a lower debt-to-equity ratio can cushion earnings in downturns. In a market favoring safety amid volatility, these stocks offer potentially steadier returns compared with richly valued tech. Investors should assess balance sheets, earnings momentum, and rate exposure, but the core message is clear: favor low-leverage, disciplined valuations in uncertain times.

5 Low-Leverage Stocks to Bet On as Investors Shy Away From Tech

December 12, 2025, 11:13 AM EST. In a week when the S&P 500 and Dow hit fresh closes as the Fed trimmed rates, investors rotated away from technology toward rate-sensitive names. The article highlights the appeal of low-leverage stocks – those with smaller debt burdens and more stable earnings. It explains leverage and the debt-to-equity ratio as key risk gauges, noting that a lower D/E can bolster solvency during downturns. It also lists candidates such as Casey’s General Stores (CASY), Hamilton Insurance Group (HG), Northrim Bancorp (NRIM), REV Group (REVG) and Engie (ENGIY) as examples of potentially safer, more resilient bets in a volatile market. The piece suggests focusing on earnings growth alongside balance-sheet strength to preserve steady returns.

Costco Beats Q1 Earnings on 6.4% Comparable Sales Growth; Membership Renewal and E-commerce Fuel Momentum

December 12, 2025, 11:12 AM EST. Costco Wholesale posted FYQ1 2026 results, delivering an EPS of $4.34 (excluding a 16-cent tax benefit) vs the Zacks consensus of $4.26, while revenue reached $67.307 billion, up 8.3% year over year and just shy of the consensus. The beat came from sustained membership growth, stronger traffic and a robust e-commerce performance, with digitally enabled sales up 20.5%. Comparable sales climbed 6.4% globally, including US +5.9%, Canada +6.5%, and international +8.8%. Revenue strength was supported by a 14% rise in membership fees to $1.329 billion; paid households rose to 81.4 million, and total cardholders hit 145.9 million. Traffic improved, and higher average ticket (+3.2%) aided margin expansion, underpinned by a customer-centric approach and ongoing membership renewal strength.

Costco Beats Q1 Earnings Estimates on 6.4% Comparable Sales Growth; Margin Gains

December 12, 2025, 11:11 AM EST. Costco Wholesale COST topped Q1 fiscal 2026 earnings expectations, delivering $4.34 per share (ex-tax benefit) vs the $4.26 expected, while revenue reached $67.307 billion, just shy of the $67.326 billion consensus. Annualized growth: 8.3% revenue and 6.4% comparable sales, with US comps +5.9% and international gains of 6.5% (Canada and Other Intl). Digitally enabled sales surged 20.5%, aided by stronger e-commerce tools and app improvements. Membership dynamics remained a theme: paid households at 81.4 million (+5.2%), with membership fees up 14% and renewal rates high (US/Canada 92.2%, worldwide 89.7%). Traffic improves, and the firm continues to emphasize value, loyalty and international expansion.

Costco Q1 FY2026: EPS Beats, 6.4% Comparable Sales Growth Driven by Membership, E-Commerce

December 12, 2025, 11:09 AM EST. Costco (COST) delivered a solid Q1 FY2026: EPS of $4.34 (ex-tax benefit) vs the Zacks estimate of $4.26, while revenue rose 8.3% to $67.307B but just missed the consensus of $67.326B. Comparable sales rose 6.4% YoY, with US comps up 5.9%, Canada 6.5% and Other International 8.8%. Digitally enabled comps jumped 20.5% on stronger e-commerce and improved app features. Membership growth continued, with paid households at 81.4M (+5.2%), membership income up 7.3% excluding FX and fees; membership fees up 14% to $1.329B. Traffic increased modestly, while the average ticket rose 3.2%. Management emphasized value, loyalty and margin expansion amid resilient demand.

Costco Beats Q1 Earnings Estimates on 6.4% Comparable Sales Growth

December 12, 2025, 11:08 AM EST. Costco (COST) topped earnings expectations in Q1 fiscal 2026, delivering EPS of $4.34 (ex-bonus) vs. the Zacks estimate of $4.26, and $4.50 including tax benefits, up from $3.82/$4.04 a year ago. Revenue of $67.3 billion narrowly missed the consensus, rising 8.3% year over year. The driver was strong membership growth and healthy traffic, with e-commerce up double digits, aided by improved personalization and app functionality. Comparable sales climbed 6.4%, led by the US (+5.9%), Canada (+6.5%) and international markets (+8.8%), with digitally enabled comps up 20.5%. Paid memberships reached 81.4 million, renewal rate in the US/Canada at 92.2% and worldwide at 89.7%. Management highlighted margin expansion and disciplined investments as it expands market share amid resilient demand for value.

Broadcom slips after earnings; Lululemon CEO to step down; Disney bets $1B on OpenAI – Morning Squawk

December 12, 2025, 11:04 AM EST. Broadcom shares fell nearly 6% premarket after beating on revenue and earnings; the company now sees current-quarter AI chip sales doubling year over year and disclosed a mystery $10 billion customer as Anthropic. Lululemon CEO Calvin McDonald will step down at the end of January, with two executives serving as interim leaders as the retailer searches for a permanent successor; the stock is up about 9%. Disney announced a $1 billion equity investment in OpenAI, linking OpenAI’s Sora platform to content initiatives. The broader market vibe: the S&P 500 and Dow closed at records while the Nasdaq lagged on AI-spending jitters after Oracle‘s results; peers like Nvidia, CoreWeave, and Micron slid, prompting rotation into cyclicals such as financials and insurers.

Broadcom earnings beat; Lululemon CEO steps down; Disney backs OpenAI – Morning Squawk

December 12, 2025, 10:55 AM EST. Morning Squawk highlights a mixed day for investors. Broadcom fell about 6% premarket after beating on earnings and signaling AI-chip sales to double year over year; it also disclosed its Anthropic customer. The AI rally cooled as Oracle slumped and peers like Nvidia, CoreWeave and Micron slid, sparking rotation into cyclicals. In corporate news, Lululemon said Calvin McDonald will step down at the end of January, with two executives serving as interim leaders as the retailer searches for a permanent successor; shares rose on the news. Costco topped estimates thanks to e-commerce strength. In a big tech-finance move, Disney announced a $1 billion equity investment in OpenAI. Traders will watch AI spending signals and leadership changes for clues on growth.

CRH Rally Fueled by Upgraded EBITDA Guidance; L1 Long Short Fund Highlights CRH in Q3 Letter

December 12, 2025, 10:54 AM EST. CRH plc (NYSE: CRH) rallied after solid Q2 earnings and an upgrade to full-year EBITDA guidance, as highlighted by the L1 Long Short Fund in its Q3 2025 letter. The fund credited CRH with offsetting weather headwinds and a softer U.S. residential market to deliver earnings growth and margin expansion, underpinned by robust infrastructure spending. With less than 40% of the IIJA budget deployed to date, the note suggests continued tailwinds for infrastructure over the medium term. As of 12/11/2025, CRH closed at $126.99 and a market cap near $85.0B. The letter also notes hedge-fund interest among CRH portfolios remains meaningful, though the fund sees greater upside in AI stocks.

Broadcom earnings beat yet stock slides; Lululemon chief to step down; Disney bets on OpenAI – Morning Squawk

December 12, 2025, 10:49 AM EST. Markets tiptoed higher as the S&P 500 and Dow climbed to fresh closes, while the Nasdaq lagged on Oracle’s 11% drop and AI-spending nerves. Broadcom rose on earnings expectations but fell nearly 6% premarket after signaling current-quarter AI-chip sales could double and revealing its mystery $10 billion customer as Anthropic. In corporate news, Lululemon said CEO Calvin McDonald will step down at the end of January, with an interim duo heading the helm as a permanent successor is sought. Costco beat estimates on strong e-commerce growth, aided by a record Black Friday for digital sales. Disney disclosed a $1 billion equity stake in OpenAI and plans around its Sora platform. Investors weighed AI volatility alongside regulatory headlines, including a new federal AI framework signed by the president.

Broadcom earnings, Lululemon CEO exit, Disney-OpenAI stake drive Morning Squawk

December 12, 2025, 10:45 AM EST. Stocks mixed as earnings and leadership moves shape the morning. Broadcom beat on both revenue and profit, but shares slid pre-market amid AI-supply chatter; the company said current-quarter AI chip sales should double and flagged a $10 billion customer as Anthropic. Lululemon named Calvin McDonald’s departure at the end of January, with two executives stepping in on an interim basis while a permanent successor search runs. The retailer also reported better-than-expected Q3 results but has underperformed in recent quarters. Costco’s early-quarter results topped forecasts on e-commerce strength. Disney unveiled a $1 billion equity investment in OpenAI, tying OpenAI’s Sora platform to Disney content. On the macro side, the S&P 500 and Dow hit new closes, Nasdaq lagged on Oracle’s AI-spending concerns, and Trump signed a national AI regulation order.

Cannabis stocks surge as Trump reclassifies marijuana to Schedule III; Tilray jumps

December 12, 2025, 10:44 AM EST. Cannabis stocks rallied after reports that Trump will push a federal reclassification of marijuana to Schedule III, a move that could ease tax rules and broaden banking access for the sector. The Washington Post and Axios described the plan, with implications for states and investors. Tilray Brands led gains, trading in double digits as traders priced in faster regulatory timelines and potential equity inflows from a more favorable tax regime. Analysts warned the path remains uncertain, but a shift could unlock cap tables and spur ETF optimism ahead of next year’s regulatory milestones, even as the year’s losses linger for many cannabis names.

Trump’s Marijuana Reclassification Sparks Cannabis Rally as Tilray Jumps 28%

December 12, 2025, 10:35 AM EST. Stocks in the cannabis sector surged after reports that President Trump will instruct federal agencies to reclassify marijuana as a Schedule III drug, a move analysts say could ease tax rules and unlock bank access for issuers. The Washington Post and Axios described the plan as likely to be announced early next year, potentially accelerating regulatory timelines and boosting investor sentiment. Tilray Brands led the rally, jumping about 28% on the news, with other cannabis names and related ETFs posting gains as dealers priced in higher upside from a more permissive regime. Analysts noted the potential for a broader capital infusion, while questions remain about implementation and timing, including any impact from court rulings on state versus federal regulation.

Cannabis stocks jump on Trump reclassification reports; Tilray surges as Schedule III talk gains ground

December 12, 2025, 10:34 AM EST. Markets rallied as reports said Trump may reclassify marijuana to Schedule III, potentially easing tax rules and expanding banking access for the industry. Cannabis stocks moved higher after the Washington Post and Axios stories, with Tilray among the biggest movers, up in double digits. A shift to a lower-risk category could speed regulatory timelines, boost capital flows, and attract institutional money. Analysts noted the potential for banks to service the sector and for states to refine rules accordingly. While the sector had struggled for years, the prospect of faster clearance from federal hurdles offered a rare bullish catalyst, though traders remain cautious about regulatory and political headwinds ahead of 2025.

Cannabis stocks surge on reports Trump will reclassify marijuana to Schedule III; Tilray jumps

December 12, 2025, 10:33 AM EST. Cannabis stocks rallied after reports that Trump will direct federal agencies to reclassify marijuana as a Schedule III drug, a move that could ease tax rules and broaden bank access for the sector. The headlines, from The Washington Post and Axios, spurred gains across the space, with Tilray Brands climbing into the double digits. Analysts described the potential shift as a catalyst for capital flows and faster regulatory timelines, though details and timing remain uncertain. If enacted, the change could bring cannabis firms under gentler tax treatment and expand states’ regulatory latitude, while keeping questions about federal action and court rulings in play. Tilray had been pressured year-to-date, making Friday’s move a notable reversal for a battered sector.

Solid Q3 Results and Guidance Lift CRH: L1 Long Short Fund Highlights CRH

December 12, 2025, 10:23 AM EST. CRH plc (NYSE: CRH) rallied in Q3 after solid second-quarter earnings and an upgrade to full-year EBITDA guidance. The L1 Long Short Fund highlighted CRH among its Q3 2025 picks, noting resilient results despite adverse weather and a softer U.S. residential market. The fund cited robust U.S. infrastructure spending and that less than 40% of the Infrastructure Investment and Jobs Act (IIJA) dollars have been deployed, implying further tailwinds. As of Dec 11, 2025, CRH traded at $126.99 with a market cap around $85.0B, underscoring its status as a reliable dividend payer and potential ballast amid broader equity strength. The letter also suggests investors may find higher upside in some AI stocks elsewhere with lower downside risk.

SEC chair pushes IPO momentum: ‘Make it cool to be a public company’

December 12, 2025, 10:15 AM EST. At a Washington conference, SEC Chair Paul Atkins urged making going public more accessible, citing three obstacles: costly, lengthy disclosures; securities-litigation risk; and politicized shareholder activists. He signaled openness to state-law bylaws with arbitration and loser-pays provisions, provided allowed by states, to reduce friction for IPOs. He expects policy proposals next year as part of regulatory work. The IPO market is rebounding in 2025, with NYSE reports of strong listings and S&P Global data showing the strongest first half since 2021 (102 IPOs, up from 78). Q2 raised about $15B and Q3 featured 23 deals of $100M+, including five over $1B. Tech, media, and telecom led activity. Executives note ongoing regulatory complexity and costs as deterrents to private firms pursuing IPOs.

CRH Gains on Solid Earnings; L1 Long Short Fund Highlights Infrastructure Tailwinds and Upgraded EBITDA Guidance

December 12, 2025, 9:58 AM EST. The L1 Long Short Fund highlighted CRH plc (NYSE: CRH) in its Q3 2025 investor letter after reporting solid Q2 earnings and upgrading its full-year EBITDA guidance. Despite adverse weather and a softer U.S. residential market, CRH delivered earnings growth and margin expansion as infrastructure spending remained robust. The fund notes ongoing IIJA tailwinds with less than 40% of Act funds deployed to date. CRH’s stock rose, with a 15.90% one-month gain and 29.69% in the last 52 weeks; as of Dec 11, 2025, it closed at $126.99 and had a market cap around $85.003B. The letter also contrasts CRH with AI stocks, which the fund sees as offering greater upside risk-reward.

CRH Rally Follows Solid Q2 Earnings and Upgraded Guidance, Flagged in L1 Long Short Fund’s Q3 2025 Letter

December 12, 2025, 9:56 AM EST. The L1 Long Short Fund’s Q3 2025 investor letter notes CRH (NYSE: CRH) as a notable beneficiary of solid Q2 earnings and an upgraded full-year EBITDA guidance. The fund posted a 13.3% quarterly return in the September quarter and 28.7% CY2025 through Q3, underscored by dovish Fed, robust U.S. earnings, and AI-driven tech advances that supported global equities. CRH’s one-month return was 15.9%; the stock has risen 29.7% over the last year, trading near $126.99 on 12/11/2025 and with a market cap around $85B. The letter cites CRH’s margin expansion, offsetting weather and a soft US housing market, plus robust IIJA infrastructure spending tailwinds.

Quantum Computing Inc. Strengthens Balance Sheet as Private Placement Fuels Next Phase of Commercialization

December 12, 2025, 9:55 AM EST. Quantum Computing Inc. (QCi) has fortified its cash runway, reporting cash and equivalents of $352.4M and investments of $460.6M for roughly $813M in liquidity, followed by an oversubscribed $750M private placement that lifts liquid assets above $1.5B. This capital cushion underpins multi-year R&D and accelerates the scaling of the thin-film lithium niobate photonics foundry, attracting talent and enabling strategic growth with minimal debt. The move signals institutional conviction and de-risked commercialization while the company sustains a modest cash burn on roughly $10M per quarter. Peer updates show D-Wave and IonQ expanding liquidity after warrants and a $2B equity offering, underscoring sector access to capital for ongoing commercialization and acquisitions. QCi’s stock has surged about 110% year over year.

SEC Chair Aims to Make Going Public Cool as IPO Momentum Rebounds in 2025

December 12, 2025, 9:48 AM EST. SEC Chairman Paul Atkins urged making going public easier as the number of public companies has fallen for decades due to costly, lengthy disclosures, litigation risk, and activist influence. He endorsed allowing arbitration and loser pays fee-shifting where permitted by state law and said the SEC won’t block IPOs for those terms. He expects related policy proposals to move through the process next year. Meanwhile, IPO momentum is reviving in 2025: NYSE executives say listings are back strong, and S&P Global data show the first half the strongest since 2021, with 102 IPOs in H1 and about $15 billion raised in Q2. Through Q3, tech, media, and telecom deals helped activity exceed 2024 levels.

SEC Chair Pushes to Make Going Public ‘Cool Again’ to Restore IPO Momentum

December 12, 2025, 9:46 AM EST. SEC Chairman Paul Atkins argued at the AICPA conference that making going public easier could reverse a 30-year decline in listed companies. He outlined three barriers: costly, lengthy disclosures; the threat of securities litigation; and politicized shareholder activism. Atkins signaled support for state-permitted bylaws that mandate arbitration and apply loser-pays fee shifts, with the SEC staff unlikely to block an IPO for such measures. He expects policy proposals to stretch into next year. The era of IPO revival appears underway in 2025, with NYSE reports of stronger listings and a year that surpassed 2024 in deal count and proceeds, though regulatory complexity remains a concern cited by CEOs.

SEC Chair Aims to Make IPOs Cooler and Revive Public Listings

December 12, 2025, 9:45 AM EST. At a Washington AICPA conference, SEC Chairman Paul Atkins urged shoring up IPO momentum by making going public more accessible. He cites a 30-year decline in publicly registered companies and outlined three roadblocks: costly, lengthy disclosures; the risk of securities litigation; and politicized shareholder activists. He signaled openness to permitting state-law arbitration and loser-pays fee-shifting, provided state law allows it, and said the SEC staff won’t block an IPO for such provisions. Atkins expects policy proposals next year as regulators weigh the changes. Meanwhile, IPO activity in 2025 has picked up, with NYSE reports of a strong market, and S&P Global data showing a strong first half and rising Q3 deals, led by tech/media/telecom.

Stock Market Holidays In 2026: NSE Shares List Of 15 Non-Trading Dates

December 12, 2025, 9:44 AM EST. Markets trade on all weekdays except Saturdays, Sundays, and exchange-declared holidays. This article outlines the NSE trading schedule and its four segments: Pre-open (Open 9:00, Close 9:08 with a last-minute random closure); Regular trading (Open 9:15, Close 3:30); Closing Session (3:40-4:00); and Block Deal Window slots (Morning 8:45-9:00 and Afternoon 14:05-14:20). It also notes the 15 forthcoming non-trading dates that NSE lists for 2026, guiding investors on planning around weekends and holidays. The timings emphasize the market’s structure for order entry, matching, and post-trade activity under the NSE framework.

Johnson Outdoors (JOUT) Q4 Loss Narrows, Revenue Beats, Stock Up Year-to-Date

December 12, 2025, 9:41 AM EST. Johnson Outdoors (JOUT) posted a Q4 loss of $0.31 per share, better than the Zacks consensus loss of $0.68 (adjusted for non-recurring items). The result marks an earnings surprise of +54.41%. A year ago the company lost $3.35 per share. The prior quarter, analysts expected $0.24 but the company earned $0.75, a +212.5% surprise. Over the last four quarters, JOUT beat EPS estimates three times and reported $135.76 million in quarterly revenue, up 15.80% from consensus. Year over year revenue rose from $105.87 million. The stock has gained about 30.3% year-to-date, outperforming the S&P 500’s 17.3%. The current outlook shows a Zacks Rank #3 (Hold); estimates for the coming quarter are -$0.45 on $121.66 million revenue and $1.05 on $616.1 million for the year.

Stock Market Holidays in 2026: NSE Announces 15 Non-Trading Dates

December 12, 2025, 9:39 AM EST. NSE has published 15 non-trading dates for 2026. Trading runs on all weekdays except Saturdays, Sundays, and the holidays announced in advance. Daily timings include a Pre-open session (9:00-9:08; with a possible random closure in the last minute), followed by the Regular trading session (9:15-3:30). The Closing Session runs 3:40-4:00. Block Deal Sessions operate in two windows: morning 8:45-9:00 and afternoon 2:05-2:20. Market participants should prepare for these fixed slots and the occasional pre-open minute closure as holidays are declared ahead of time.

Stock Market Holidays in 2026: NSE Announces 15 Non-Trading Dates

December 12, 2025, 9:36 AM EST. An NSE calendar for 2026 lists 15 non-trading dates. Trading runs on weekdays, excluding Saturdays, Sundays, and exchange-declared holidays. The schedule covers: Pre-open 9:00-9:08 (order entry/closure with last-minute tweaks), Regular 9:15-3:30, Closing 3:40-4:00, and Block Deal sessions (morning 8:45-9:00; afternoon 2:05-2:20). Traders should mark these timings and the 15 holidays to plan orders and avoid rejects. This piece highlights NSE’s 2026 calendar and the impact on liquidity and trading hours.

Stock Market Holidays In 2026: NSE Lists 15 Non-Trading Dates

December 12, 2025, 9:35 AM EST. India’s NSE has set aside 15 non-trading dates in 2026, with trading confined to weekdays excluding weekends and declared holidays. The equities segment operates under a multi-session structure: Pre-open (9:00-9:08 am, with final minute closures), Regular trading (9:15 am-3:30 pm), Closing session (3:40-4:00 pm), and Block Deal Sessions (Morning: 8:45-9:00 am; Afternoon: 2:05-2:20 pm). Market participants should monitor exchange notices for holidays announced in advance to avoid settlements and ensure order placement aligns with session timings.

Haemonetics Stock: NexSys PCS Growth and Hospital Recovery in Focus, but FX and Debt Risks

December 12, 2025, 9:33 AM EST. Haemonetics (HAE) faces a mixed outlook. A recovering Hospital business and strong NexSys PCS uptake underpin near- to mid-term growth. The NexSys PCS plasma collection system, aided by Persona Technology, is boosting yield (9-12%) and has logged over 40 million collections, while the Hospital segment expanded revenues by 5% in Q2. Blood Management Technologies rose 12%, and Vascular Closure devices contributed, with new viscoelastic testing cartridges rolling out in EMEA and Japan. However, challenges persist: nearly 27% of sales are international, exposing HAE to foreign exchange headwinds, and solvency remains a concern with cash around $296m against near-term debt of $304m and long-term debt of $920m (debt-to-capital ~52%; current ratio ~1.64). Given Zacks Rank #3 (Hold), the stock offers upside potential but risk from macro and debt.

NSE 2026 Trading Holidays: 15 Market Holidays, Weekend Surprises, and Muhurat Trading

December 12, 2025, 9:32 AM EST. The NSE has released the 2026 trading calendar with 15 market holidays across cash and derivatives, one more than this year. Key dates span Republic Day, Holi, Ram Navami, Good Friday, Ambedkar Jayanti, Maharashtra Day, Bakri-Id, Muhurat Trading in November, and Christmas. Four major holidays fall on weekends, so there is no market closure on those dates; Diwali is not listed since it lands on a Sunday, with the Muhurat session slated for November 8. The calendar helps investors plan portfolio rebalancing, derivatives expiry strategies, and liquidity planning. Analysts peg 2026 as a potential recovery year for Indian equities, with targets around Nifty 30,000 to 32,032 by year-end, though risks remain.

Card Factory plc stock plunges after profit warning; FY26 PBT guidance cut to £55m-£60m

December 12, 2025, 9:27 AM EST. London | 12 December 2025 – Card Factory Plc shares plunged after a surprise profit warning, trimming its FY26 adjusted PBT guidance to £55m-£60m from FY25’s £66.0m. The retailer cited weaker UK consumer confidence and soft high-street footfall, with UK store sales running below prior expectations into December. The stock fell about 26% to around 71p, after closing at 96.40p. Reuters framed the move as a 9%-16.6% decline versus last year. Management pointed to stabilisers: Ireland and North America in line, Funky Pigeon integration on track, and progress on the Simplify and Scale programme. The company had been buying back shares before the sell-off.

Tilray Stock Rockets 32% After Hours on Amped Live Resin Launch and Marijuana Rescheduling Talk

December 12, 2025, 9:24 AM EST. Tilray Brands (TLRY) jumped about 32% in after-hours trade to $11.09 after unveiling its Amped Live Resin Liquid Diamond 1g 510 cartridges under the Redecan brand, featuring Space Age CK and Blueberry DNTS strains with 80% Legit Live Resin and 20% Liquid Diamonds. The launch marks Redecan’s first live resin-liquid diamond line, boosted by a TrueDraw Ceramic core and a wide-body design for better airflow. In regular session, shares rose 2.1% to close at $8.43. Analysts maintain a Hold rating with a $20 average price target. The move also followed reports that President Trump may direct agencies to reclassify marijuana from Schedule I to Schedule III, though White House officials say no final decision has been made.

3 TSX Penny Stocks With Market Caps Over CA$400M To Watch in 2025

December 12, 2025, 9:23 AM EST. As the TSX advances into late 2025, investors are spotlighting penny stocks that boast market caps above CA$400 million. The list features names like Westbridge Renewable Energy (WEB), Sailfish Royalty (FISH), Zoomd Technologies (ZOMD), Thor Explorations (THX) and more, highlighting a mix of energy, mining and growth plays. The article notes strong liquidity and high financial health ratings across several tickers, with market caps from CA$21 million to CA$831 million. It also references Steppe Gold Ltd. (STGO) and its solid balance sheet and attractive P/E around 8.4x, alongside steady demand for precious metals. For investors, the takeaway is to monitor liquidity, earnings trends and insider activity while considering central-bank policy and labour-market dynamics as 2026 approaches.

Regulatory Notice to Noteholders: North Westerly VI ESG CLO DAC at Euronext Dublin

December 12, 2025, 9:18 AM EST. Regulatory notice issued by Euronext Dublin to noteholders of North Westerly VI ESG CLO DAC highlights key disclosures and reference data providers. The communication confirms that market data is provided by ICE Data Services, reference data by FactSet, and confirms copyright notices from FactSet and the American Bankers Association. It notes that SEC filings and related documents are supplied by Quartr and that market access is supported by services from TradingView. The notice is part of ongoing issuer disclosure to investors, emphasizing transparency around static data, CUSIP identifiers, and compliance obligations for the ESG CLO vehicle. Investors should review accompanying documents for material information and timing.

Redecan Expands Diamond Vape Segment with Amped Live Resin Liquid Diamond Vapes

December 12, 2025, 9:17 AM EST. Tilray Brands announces the launch of Amped Live Resin Liquid Diamond 1g 510 cartridges, Redecan’s first live resin-liquid diamond line. The debut lineup, Space Age CK and Blueberry DNTS, blends 80% Legit Live Resin with 20% Liquid Diamonds to deliver true-to-strain flavour. Each cartridge is 100% pure cannabis extract with no fillers, grown, extracted, filled, and packed in-house. Amped features the TrueDraw Ceramic core and wide-body design for a smooth draw and reduced clog risk. The market shows 6.3% category growth for Live Resin Vapes over six months, with winter basket penetration peaking Dec-Feb. Available in Canada (Ontario & Alberta) now; national distribution planned for early 2026. Must be 19+, consume responsibly.

REG – Euronext Dublin: Notice of Potential Redemption for CAPITAL FOUR CLO VII DAC

December 12, 2025, 9:12 AM EST. REG announces a Notice of Potential Redemption for CAPITAL FOUR CLO VII DAC on Euronext Dublin. The issuer, a CLO in designated activity company form, may redeem all or part of its outstanding notes under defined terms and timelines. The disclosure signals a potential redemption event subject to conditions and regulatory approvals. Investors should review the issuer’s official notices and the prospectus for details on redemption prices, notice periods, and post-redemption steps. This is not a confirmation of redemption and should be considered alongside current market conditions and CLO market dynamics.

Reach Subsea ASA receives application for bond listing on Euronext Oslo Børs

December 12, 2025, 9:11 AM EST. Reach Subsea ASA has received an application for listing of bonds on Euronext Oslo Børs. The move aims to diversify funding and enhance liquidity by listing its bond issue on the exchange. The process is subject to regulatory approvals and market conditions. The report references data from ICE Data Services and FactSet, with related filings and documents provided by Quartr and TradingView.

Euronext extends two-hour evening trading session for agricultural futures

December 12, 2025, 9:10 AM EST. Euronext will add a two-hour evening trading session for its milling wheat, rapeseed and maize futures from February 2, expanding hours from 10:45 a.m.-6:30 p.m. CET to 6:30-8:30 p.m. CET. The move, previously noted by Reuters, aims to attract more U.S.-based investors and boost liquidity in the global price benchmarks for agricultural futures alongside CME’s grain products. The extension applies to all expiries except the front month in the last three days before expiration; the daily settlement remains at 6:30 p.m. CET, and trades in the extra session count toward the same day’s open interest and volume and are marked-to-market at the 6:30 p.m. settlement.

Lion Finance Group PLC: CEO Archil Gachechiladze sells shares for estate planning, retains majority stake

December 12, 2025, 9:09 AM EST. Lion Finance Group PLC disclosed that on 9-11 December 2025 Chief Executive Officer Archil Gachechiladze sold a portion of his Ordinary Shares, retaining 91% of his economic interest. The CEO signed a three-year contract (renewable in 2028) and continues to receive about 90% of compensation in the form of Shares, subject to long-term holding and vesting. The sale was for personal estate planning reasons. Details note the Ordinary shares with ISIN GB00BF4HYT85 traded around £92-£93. The disclosure complies with the UK Market Abuse Regulation; Gachechiladze is a PDMR and Lion Finance Group PLC trades on the LSE.

HIVE Digital Technologies Lists on Colombia’s Stock Exchange, Expanding AI and Renewable HPC Footprint

December 12, 2025, 9:06 AM EST. HIVE Digital Technologies (TSE:HIVE) has announced its listing on the Colombian Stock Exchange, marking its entry into Colombia’s capital markets and expanding its footprint in green AI and Bitcoin infrastructure in Latin America. The move aims to boost visibility among investors as the company shifts from Bitcoin mining toward AI and HPC cloud infrastructure, powered by renewable energy. Analysts note a Hold rating with a C$4.50 target, while Spark’s AI Analyst praises growth but flags profitability challenges, a negative P/E, and no dividend yield. Overall sentiment cites strong revenue growth and strategic expansions, tempered by bearish technical indicators. HIVE operates across Canada, Sweden, and Paraguay, and its evolving business mix centers on sustainable high-performance computing and next-gen AI infra.

Fastenal Named Top Socially Responsible Dividend Stock with 2.1% Yield (FAST)

December 12, 2025, 8:58 AM EST. Fastenal Co. (FAST) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signaling a strong DividendRank and an above-average 2.1% yield. The award weighs environmental and social criteria, including energy efficiency and human rights. FAST also appears in the iShares USA ESG Select ETF (SUSA), with about 0.15% of the fund and roughly $7.5 million of FAST shares. The annualized dividend is $0.88 per share, paid quarterly, with the most recent ex-date on 10/28/2025. Operating in the Home Improvement Stores sector, FAST sits among peers like HD and LOW, highlighting both income potential and ESG appeal for investors.

Rivian Stock Falls After Autonomy Day Highlights In-House AI Chip and Expanded Self-Driving Roadmap

December 12, 2025, 8:56 AM EST. Rivian (RIVN) fell more than 6% after its Autonomy and AI Day outlined a broader push into AI and self-driving features. The company unveiled an in-house processor claimed to deliver roughly four times the computing power of the current system, replacing Nvidia chips. Rivian plans to add lidar to the upcoming R2 SUV (2025) and will combine cameras and radars to bolster safety and driver-assistance features. CEO R.J. Scaringe said hands-off, eyes-on driving could reach more than 3.5 million roads by year-end, with point-to-point navigation in 2025 and later eyes-off capability. An AI assistant due in early 2026 and a new Autonomy+ subscription could generate recurring revenue as production and autonomy software scale.

L1 Capital trims HCA Healthcare after rally; Q3 2025 investor letter flags balanced outlook

December 12, 2025, 8:55 AM EST. In its Q3 2025 letter, L1 Capital International Fund says it trimmed HCA Healthcare (NYSE:HCA) after a sharp rally, though the stake remains held and no longer a top-10 holding. The fund posted a 2.6% quarterly return versus the 6.1% benchmark (MSCI World Net Total Return Index in AUD). The note reiterates HCA’s leadership in U.S. for-profit hospitals and outpatient services, with management viewing recent regulatory worries as creating attractive entry points in the past; today, operating conditions are viewed as more balanced and risk-adjusted upside less favorable. HCA shows momentum with a 52-week gain of 53.65% and a Dec. 11, 2025 close of $482.35 and a $112.867B market cap. The letter also cites AI stocks as having greater upside and notes HCA isn’t among the 30 most popular hedge fund ideas.

Analysts Bullish on ACM Research (ACMR) as Ultra Lith Baker Launch Highlights a High-Growth Path

December 12, 2025, 8:54 AM EST. ACM Research, a key semiconductor equipment player, has strong analyst sentiment with 88% of 8 analysts rating it a Buy. In November, the company delivered its first Ultra Lith Baker system to a leading display-panel maker, addressing critical-dimension fluctuation and thermal drift in advanced lithography. The system features precise temperature control, UV curing with ±5% intensity consistency, and heat management aimed at reducing overlay error and pattern distortion, potentially lifting yield. CEO Dr. David Wang says the Track-series deployment marks ACMR’s entry into high-volume display manufacturing, with flexible exposure modes for future nodes. 2025 guidance was trimmed to $875M-$925M, reflecting AI-driven demand and ongoing product innovation. While attractive, some AI stocks may offer greater upside with different risk profiles.

Eli Lilly Stock Price Prediction and Forecast 2025-2030: Key Drivers and Valuation

December 12, 2025, 8:53 AM EST. From 2020 to 2024, Eli Lilly (NYSE: LLY) staged a remarkable rally, powered by a pipeline rich in GLP-1 drugs and solid earnings, but faces near-term volatility and intense weight-loss competition. This piece summarizes Lilly’s latest results-strong Q3 performance, a 15% dividend increase, and a collaboration with Nvidia-along with plans for a $6 billion Huntsville facility. With the stock trading at a premium, the question is whether the rally can persist into 2025-2030. We review projected revenue and net income growth and the key growth engines: a robust innovative drug pipeline featuring Mounjaro, Zepbound, Jardiance, Taltz, and Verzenio. We also weigh risks from competition, regulatory shifts, and pipeline timing.

Card Factory PLC Stock Plunges on Profit Warning Amid Softer UK Consumers

December 12, 2025, 8:49 AM EST. Card Factory Plc warned of a lower FY26 profit, cutting adjusted PBT to £55m-£60m from FY25’s £66.0m, hit by weaker UK consumer confidence and soft high-street footfall. The update sent shares from about 96p to the 70p area, around a 26% intraday drop and a multi-year low per Reuters. Analysts described the downgrade as a surprise, given earlier guidance for mid-to-high single-digit growth. Management noted stabilisers: Ireland and North America in line, Funky Pigeon on track, and progress on the ‘Simplify and Scale’ programme. The company had been buying back shares prior to the sell-off. The festive period will test whether the revised guidance can be met, with seven weeks left in the year.

Tilray Stock Teeters on Death Cross as Trump Cannabis Reform Silence Spooks Traders

December 12, 2025, 8:48 AM EST. Tilray Brands’ stock has plunged from a high of $23.15 to $7.20, with a looming death cross as the 50-day EMA nears the 200-day EMA. The stock has broken below key support at $10.35, while RSI and the Stochastic Oscillator sit in oversold territory and the ADX climbs, signaling a strengthening downtrend. A break below $7.20 could push toward the psychological $5 level; a sustained move above $10.35 would threaten the bearish setup and hint at a rebound toward $15. The cannabis space has weakened broadly, with MSOS down ~40% from August highs; Trump‘s muted stance on cannabis reclassification remains a key overhang, alongside mixed results from Tilray’s beverage segment and modest cannabis revenue growth.

Entegris (ENTG) Falls as Guidance Misses; AI Rally Overshadows Fundamentals in 3Q25 Letter

December 12, 2025, 8:45 AM EST. Market notes on Entegris, Inc. (ENTG) follow a third-quarter 2025 letter from Mairs & Power Balanced Fund highlighting mixed signals. The fund’s nine-month return was 6.47%, lagging benchmarks up 11.35% and peers at 10.73%. ENTG beat earnings but guided below estimates due to margin pressure from expansion and soft demand. One-month return: 22.62%; shares off about 10% over 52 weeks. On Dec 11, 2025, ENTG closed at $95.99 and carried a market cap around $14.6B. The Information Technology sector led the period’s underperformance as AI beneficiaries rose, while ENTG, MSI, and TXN lagged. Hedge funds owned ENTG: 38 positions in Q3, down from 54.

U.S. Stock Market Today (Dec. 12, 2025): S&P 500 Futures Slip as AI Spending Jitters Return, Dow Holds Near Record Highs

December 12, 2025, 8:44 AM EST. U.S. stocks enter Friday with mixed signals. Dow futures edge higher while S&P 500 and Nasdaq futures slip as investors reassess the profitability of the AI buildout. In early trade, Dow E-minis +0.17%, S&P 500 E-minis -0.20%, and Nasdaq 100 E-minis -0.56%. The market weighs an ongoing AI rally against margin concerns after Broadcom warned margins could soften due to AI mix, pressuring semis such as AMD and Nvidia. Oracle also sparked caution with a larger capex plan for fiscal 2026, renewing questions about AI payback timing. Yet the broader backdrop of rate-cut optimism and breadth beyond mega-caps helps the Dow hover near record highs as traders scrutinize AI revenue quality.

Tilray Stock Near Death Cross as Trump Silence on Cannabis Reform Spooks Investors

December 12, 2025, 8:43 AM EST. Tilray Brands has slumped from a high of $23.15 on Oct 9 to $7.20, placing it near a death cross as the 50-day EMA looks set to cross the 200-day EMA. The stock has fallen below key moving averages, with the next major support near $5 and a pivotal test of $10.35. Technicals show RSI and Stochastic in oversold territory while the ADX climbs, signaling renewed downside momentum. A break above $10.35 would invalidate the bearish outlook and open a move toward $15. The broader cannabis group is weak: the MSOS ETF has plunged about 40% from August highs, and peers like Curaleaf and Green Thumb have fallen. Trump’s muted stance on cannabis reclassification compounds sentiment, alongside soft results in Tilray’s beverage segment.

U.S. Stock Market Today (Dec. 12, 2025): AI Spending Jitters Return as Dow Holds Near Records; S&P 500 Futures Dip

December 12, 2025, 8:41 AM EST. Stocks edge into Friday with a split tone: Dow futures modestly higher while S&P 500 and Nasdaq futures slip as investors reassess the AI buildout’s profitability. In premarket trading, Dow E-minis +0.17%, S&P 500 E-minis -0.20%, Nasdaq-100 E-minis -0.56%. The market remains torn between AI spending strength and concerns about margins and payback. Broadcom warned that a higher mix of AI business could pressure future margins, weighing on peers like AMD and Nvidia. Oracle also stirred caution after guiding an extra ~$15 billion in AI capex for fiscal 2026. The backdrop remains a tug-of-war between rate-cut optimism and a widening AI bubble debate, with traders watching whether a broader rally in financials, materials, value, and small caps can persist if AI enthusiasm cools.

AstraZeneca AZN in the Analyst Spotlight as Price Targets Rise

December 12, 2025, 8:36 AM EST. Analysts are ramping up attention on AstraZeneca (AZN) after multiple firms boosted price targets and reiterated bullish calls. TD Cowen lifted AZN’s target to $105 from $95 and maintained a Buy rating, citing a strong drug pipeline and growth exposure in high-growth markets. Morgan Stanley had already increased its target to $103 from $93, highlighting a stable pharmaceutical market and upside from late-stage assets. Bank of America also added AstraZeneca to its 2026 top-stocks list, raising the target to $108.50 from $91.70, pointing to the suite of candidates such as SERENA-4, Eplontersen, and AVANZAR. While other AI stocks may offer greater upside, AZN remains a notable name in the pharma equity landscape.

AstraZeneca AZN Draws Fresh Analyst Upgrades as Pipeline Rally Persists

December 12, 2025, 8:35 AM EST. Shares of AstraZeneca PLC (AZN) drew fresh analyst attention after TD Cowen hiked the target to $105 from $95 with a Buy rating, citing a robust drug pipeline and exposure to high-growth markets. Earlier, Morgan Stanley boosted its target to $103 from $93, noting a stable core pharmaceutical market and upside from the pipeline. Bank of America joined the wave, adding AZN to its 2026 top stocks list and lifting the target to $108.50 from $91.70. The upgrades center on a potential pipeline featuring SERENA-4, Eplontersen, and AVANZAR, with applications including a rare neuropathy and non-small cell lung cancer, underscoring renewed optimism around AZN despite broader market debates.

5 Stock Splits That Could Happen in 2026: Microsoft, MercadoLibre, Goldman Sachs in Focus

December 12, 2025, 8:30 AM EST. Stock splits can trigger a short-term pop as investors price in the event. The piece surveys five potential split candidates for 2026, noting that such splits are not a strong investment thesis but can reflect management optimism and help with option-based compensation. Highlights include Microsoft (around $483-$500), MercadoLibre (roughly $2,000 per share), and Goldman Sachs (about $850-$911). Splits do not change fundamentals, but they can reduce per-share prices and attract fresh demand around announcements, potentially offering a tactical edge for an investing strategy rather than a long-haul thesis.

Novartis (NVS) Signs $1.7B Development Deal with Relation Therapeutics, Buoys AI-Driven Pipeline

December 12, 2025, 8:28 AM EST. Swiss pharma giant Novartis (NYSE: NVS) inked a $1.7 billion partnership with Relation Therapeutics to develop allergic-disease drugs using Relation’s AI platform and genetics research. Bloomberg reported the deal surfaced on December 9. A day earlier, JPMorgan upgraded NVS to Overweight and lifted the price target to CHF125. In 2025, Novartis has pursued multiple bets, including a $12 billion acquisition of Avidity Biosciences to expand RNA therapies, plus announced or rumored deals for Tourmaline Bio ($1.4B) and Regulus Therapeutics ($1.7B) to bolster cardiovascular and renal portfolios. The piece notes AI-driven drug discovery and onshoring as tailwinds, while suggesting some AI stocks may offer different risk/return profiles.

Five Stocks That Could Split in 2026: Microsoft, MercadoLibre, Goldman Sachs and More

December 12, 2025, 8:24 AM EST. Five stocks could announce splits in 2026, a move that often yields a one-time price pop and attracts investor attention. Splits are rarer now, but they can signal the underlying business is healthy and make shares more accessible for compensation plans. The highlighted candidates include Microsoft (MSFT), whose stock sits around $500 after a long gap since the last split; MercadoLibre (MELI), near $2,000 and historically reluctant to split; and Goldman Sachs (GS), around $850 with a heavy Dow weight. Importantly, a split is not an investment thesis-the real driver is fundamentals, with the split serving as a near-term catalyst if announced.

Novartis Strikes $1.7 Billion Development Deal With Relation Therapeutics Powered by AI

December 12, 2025, 8:23 AM EST. Swiss pharma giant Novartis (NYSE: NVS) has inked a $1.7 billion development deal with Relation Therapeutics to use its AI platform to uncover new drugs by analyzing disease genetics, according to a Bloomberg report dated Dec. 9. The move follows an earlier JPMorgan upgrade that lifted the price target to CHF125, signaling optimism for 2026. In 2025, Novartis has pursued several deals, including the acquisition of Avidity Biosciences for $12 billion to bolster RNA therapies, plus planned purchases of Tourmaline Bio ($1.4B) and Regulus Therapeutics ($1.7B) to expand renal and cardiovascular portfolios. The firm remains confident about growth, while other AI stocks offer contested risk/return profiles.

ASX Climb on Santa Rally as Miners and Gold Stocks Lead Gains – Weekly Wrap

December 12, 2025, 8:20 AM EST. ASX closed higher as the Santa rally appears to take hold, with the ASX 200 up 105.3 points (1.2%) to 8,697.3 and the week edging higher by 0.7%. Miners led the charge: BHP and Fortescue +1.1%, Rio Tinto +2.5%. Gold miners were the day’s standout, with Northern Star +2.9%, Evolution Mining +4.2% and Newmont +5.7% after spot gold neared $4,280/oz; Greatland Resources jumped 9.9%. Banks also rose: CBA +2.1%, NAB +1.8%, Westpac +1.4%, ANZ +1.2%, despite news around Shayne Elliott. Oil & gas slipped: Santos -0.5%, Woodside -0.08%. Technology softer on Oracle’s 10.8% drop; TNE -1.6%, XRO -0.5%. Looking ahead: MYEFO deficit around $32b; central-bank divergence remains a theme; the Santa rally looks intact.

Entegris (ENTG) Guidance Miss Sends Stock Lower as AI Rally Fades, Mairs & Power Letter Indicates

December 12, 2025, 8:19 AM EST. In its Q3 2025 investor letter, Mairs & Power Balanced Fund flagged Entegris (ENTG) as a laggard after guidance missed estimates and margin pressure weighed on the stock. The Information Technology sector dragged, while a handful of AI names surged and the Fund remained underexposed. ENTG posted Q3 2025 sales of $807 million, flat year over year and up 2% sequentially; the stock traded near $95.99 on Dec 11, 2025, for a $14.552 billion market cap. The letter also mentions other holdings like Motorola Solutions and Texas Instruments as laggards. Despite the setback, the piece notes potential upside in select AI stocks and ongoing portfolio positioning amid the AI rotation.

British American Tobacco (BTI) 2026 Revenue Growth Guidance Signals Cautious Outlook

December 12, 2025, 8:18 AM EST. British American Tobacco (BTI) maintains a cautious 2026 outlook, guiding revenue at the low end of its 3%-5% mid-term growth guidance and adjusted operating profit at the low end of 4%-6%. For the current year, BTI still expects ~2% revenue and profit growth. The group contends with headwinds from vaping and e-cigarettes; it halted a US pilot for an unlicensed vape and notes the category is pressured by illicit activity. Management expects Vuse to be harmed by illicit proliferation but believes the brand can benefit from stronger enforcement. Despite the mixed outlook, BTI remains a top ADR, though some investors may prefer AI names with potentially higher returns and different risk profiles.

BTI 2026 Revenue Growth at Low End of Guidance; Vuse Headwinds

December 12, 2025, 8:17 AM EST. BTI signaled that 2026 revenue will sit at the low end of its mid-term growth target of 3%-5%, and 2026 adjusted profit from operations at the low end of 4%-6%. For the current year, BTI expects revenue and adjusted profit to grow by 2% each. The group is confronting a shift to vaping and e-cigarettes, halting a pilot for an unlicensed US vape and noting illicit proliferation in the vapor category. Management says Vuse should benefit from stronger enforcement, though revenue for Vuse could decline in the high single digits due to these factors. The article also pivots to noting that AI stocks may offer greater upside with potentially lower risk. Disclosure: None.

Glen Burnie Bancorp to Voluntarily Delist From Nasdaq, Deregister Shares and Move to OTCQX

December 12, 2025, 8:16 AM EST. Glen Burnie Bancorp announced that its board has approved a voluntary delisting of its common stock from Nasdaq and the subsequent deregistration of its shares with the SEC to suspend reporting under the Exchange Act. The company plans to file a Form 25 around December 22, 2025, with the delisting becoming effective January 1, 2026 and trading on Nasdaq expected to be suspended upon filing. Bancorp intends to trade on the OTCQX platform to provide liquidity for shareholders, though there is no guarantee a broker will quote or maintain a market. A Form 15 to deregister is anticipated around January 2, 2026, after which most reporting obligations end.

Glen Burnie Bancorp to Voluntarily Delist from Nasdaq, Deregister with SEC, and Move Trading to OTCQX

December 12, 2025, 8:15 AM EST. Glen Burnie Bancorp announced its board approved a voluntary delisting of its common stock from Nasdaq and the subsequent SEC deregistration to terminate reporting under the Exchange Act. The company plans to file a Form 25 around December 22, 2025, with the delisting becoming effective January 1, 2026, and trading to be suspended near filing. Bancorp intends to switch liquidity to the OTCQX platform after applying for quotation. It will file a Form 15 later to certify fewer than 1,200 shareholders, suspending most Exchange Act reporting. The move carries no guarantee of broker quotes or continued trading and will rely on ongoing investor information to support a market.

GLPG Crosses Above Average Analyst Target, Trading at $32.57

December 12, 2025, 8:14 AM EST. Galapagos NV (GLPG) has crossed above the average 12-month target of $32.50, trading at $32.57. When a stock hits a target, analysts may react by downgrading on valuation or raising the target if fundamentals justify it. The move appears tied to a blend of company developments and broader sentiment rather than a single catalyst. In Zacks’ coverage, Strong Buy: 1, Buy: 0, Hold: 5, Sell: 2, Strong Sell: 3, with an average rating of 3.52. The piece frames the target as a wisdom of crowds signal, inviting investors to decide whether $32.50 is a waypoint or a caution flag. Data cited from Zacks via Quandl.

ASX Climbs on Santa Rally as Miners and Gold Stocks Lead Gains – Weekly Wrap

December 12, 2025, 8:07 AM EST. ASX finished Friday higher on a Santa Rally push, with the ASX 200 up 1.2% to 8,697.30 and weekly gains of about 0.7%. Miners led the charge: BHP and Fortescue rose around 1.1% while Rio Tinto jumped 2.5%. Gold miners climbed, with Northern Star up 2.9%, Evolution Mining 4.2% and Newmont 5.7% as spot gold topped US$4,280/oz; Greatland Resources surged 9.9% as a standout large cap. Banks also advanced, with CBA up 2.1%, NAB 1.8%, WBC 1.4% and ANZ 1.2%, despite headlines around executive pay. Oil and gas slipped, with Santos and Woodside down. Traders eye the upcoming MYEFO and potential central-bank divergence as the Christmas break nears.

BOK Financial Reaches Analyst Target Price; Analysts Consider Next Move

December 12, 2025, 8:05 AM EST. Shares of BOK Financial Corp (BOKF) traded at $103.19 after crossing above the consensus 12-month target price of $102.43. With the stock poised at a level just above the average target, analysts face a choice: refresh the target price higher or reassess on valuation. The Zacks-covered group shows 7 holdings with a broad mix: several Hold ratings, and one lower target as low as $80 and a high as $115. The current average rating is about 2.75 on the 1-5 scale (closer to Hold). The piece cites wisdom of crowds in aggregating targets, inviting investors to decide whether the run continues or profits are taken. Data from Zacks via Quandl.

BOK Financial Shares Trade Above Avg Analyst Target; Analysts Split on Outlook

December 12, 2025, 8:04 AM EST. BOK Financial Corp (BOKF) shares traded at about $103.19, topping the consensus 12-month target of $102.43. When a stock surpasses an analyst target, firms may either downgrade on valuation or lift targets; in this case, sentiment hinges on fundamentals behind the move. Across Zacks‘ coverage, 7 analysts contribute to the average target, with a low of $80 and a high of $115; the dispersion (standard deviation) is about $11.12. The takeaway is the crowd’s view: is $102.43 just a stepping stone or has the valuation stretched? The current analyst mix shows 1 Strong Buy, 7 Holds, no Sells, with an average rating of 2.75 (on a 1-5 scale). Data cited from Zacks Investment Research via Quandl.

Galapagos GLPG Crosses Above Average Analyst Target; Outlook Remains Mixed

December 12, 2025, 8:01 AM EST. Galapagos NV (GLPG) shares traded at $32.57, edging above the consensus 12-month target of $32.50. When a stock hits an analyst target, revisions may come from valuation shifts or fresh fundamentals. For GLPG, five Zacks targets span $22.00 to $40.50, with a standard deviation of about $7.92. The move above the average target highlights the crowd’s mixed view: potential upside toward the high end of the range, or a reminder that the valuation could be stretched. The latest ratings table shows a mix of Strong Buy, Buy, Hold, and Sell signals, with an average rating near 3.5 on a 1-to-5 scale. Investors should weigh near-term catalysts and risks before adjusting positions.

Timken Stock Tops Avg 12-Month Target, Trading at $85.14

December 12, 2025, 8:00 AM EST. Timken Co. (TKR) traded at $85.14, atop the Street’s average 12-month target of $84.40. With 10 targets in the mix, ranging from $71 to $97 and a standard deviation of $8.54, the analyst view is varied. Crossing the target can trigger a reassessment: some strategists raise the target if fundamentals stay supportive, others view valuations as extended. The latest breakdown shows a leaning toward Hold with an average rating near 2.1 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell), per Zacks via Quandl. Investors should weigh new company developments against the target backdrop to decide whether to add, trim, or take profits.

Timken Reaches Analyst Target Price: Investors Weigh Next Move for TKR

December 12, 2025, 7:59 AM EST. Timken Co. (TKR) shares rose to $85.14, topping the 12-month analyst target of $84.40 and underscoring how a price move can trigger analyst re-evaluation. With 10 targets contributing to the average, there is a wide range-from a low $71 to as high as $97, with a standard deviation of $8.54-reflecting mixed views on growth and margins. The takeaway: the crowd’s target acts as a guide, not a guarantee, prompting investors to decide whether $84.40 is a stepping stone to higher targets or a signal the stock has stretched valuations. Current ratings show: Strong Buy 5, Buy 0, Hold 4, Sell 1, Strong Sell 0, average rating 2.1. Data from Zacks via Quandl.

Becton, Dickinson Stock Trades Above 12-Month Target as Analysts Weigh In

December 12, 2025, 7:58 AM EST. BDX shares rose to $200.43 in recent trade, edging past the composite 12-month target of $200.40 cited by analysts. When a stock hits an analyst target, reactions vary: some downgrade, others lift targets; fundamentals and company news often drive revisions. Across Zacks coverage, there are 10 price targets for Becton, Dickinson & Co, with an average of $200.40. Targets span from a low around $183 to a high near $230, with a standard deviation of about $15.54. The idea behind the wisdom of crowds is that the aggregated view can reveal the path forward for BDX, not just one expert’s call. Current analyst ratings show Strong Buy or Buy on a minority vs Hold on most estimates, averaging around 2.3 on a 1-5 scale.

BDX Reaches Analyst Target Price of $200.40; Analysts Weigh Next Move

December 12, 2025, 7:57 AM EST. Becton, Dickinson & Co (BDX) stock trades at $200.43 after crossing above the average 12-month target of $200.40. With the price now above that target, analysts may either raise targets or reassess valuation. Ten targets from Zacks Investment Research span $183.00 to $230.00, with a standard deviation of $15.54. The piece highlights the wisdom of crowds behind the target and invites investors to decide whether the move signals momentum or potential overvaluation. Current ratings show a mix of Strong Buys and Holds, averaging 2.33 on a 1-5 scale, with no Sells on the table.

RXO Reaches Analyst Target Price as Shares Trade at $20.12

December 12, 2025, 7:56 AM EST. RXO Inc shares rose above the mean 12-month target of $20.07, trading near $20.12 as of the latest session. The move spotlights the analyst community’s range of targets, with a low of $15 and a high of $25 among 14 Zacks-covered estimates, and a standard deviation of about $3.02, illustrating a notable dispersion. The wrap shows a market wrestling with whether the current price already reflects fundamentals or if room remains for further upside. Analysts covering RXO show a mixed bias: several Strong Buys, many Holds, and a number of Strong Sells, yielding an average rating near 2.87 on a 1 to 5 scale. Investors should weigh fundamentals as future earnings and operations drive any re-rate, rather than a single target. Source: Zacks via Quandl.

RXO Reaches Analyst Target; Mixed Ratings and Wide Target Range

December 12, 2025, 7:55 AM EST. RXO Inc (RXO) traded near $20.12, nudging above the $20.07 average target from 14 analysts. Crossing a target can prompt analysts to raise or recalibrate their views, depending on ongoing company developments. The targets span from a low around $15 to a high near $25, with a standard deviation of about $3.02, underscoring a broad range of opinions within Zacks’ coverage. The current ratings mix shows Strong Buy (4), Hold (8), and Strong Sell (3), yielding an average rating of 2.87 on a 1-5 scale (1=Strong Buy). Data come from Zacks Investment Research via Quandl; the views expressed reflect the author, not Nasdaq.

FG Crosses Above Average Analyst Target as Shares Trade at $34.93

December 12, 2025, 7:53 AM EST. FG shares traded at $34.93, topping the average 12-month analyst target of $34.33. With the stock nudging above the target, analysts may reassess-either by downgrading on valuation or lifting targets if fundamentals improve. The Zacks-covered set shows three targets contributing to the average, with one as low as $33.00 and another as high as $35.00; the dispersion (standard deviation) is about $1.15. The idea behind the average is the wisdom of crowds. The current analyst ratings show: Strong Buy 1, Buy 0, Hold 3, Sell 0, Strong Sell 0, for an average rating of 2.5. Data from Zacks via Quandl. Investors face whether $34.33 is a stepping stone or a sign of overvaluation.

FG Crosses Above Average Analyst Target as Price Reaches $34.93

December 12, 2025, 7:52 AM EST. Shares of FG crossed above the average analyst 12-month target of $34.33 and traded near $34.93. When a target is breached, analysts may either downgrade on valuation or raise targets, depending on fundamental drivers-if the business improves, a higher target may follow. There are three targets contributing to the Zacks mean; one analyst sees $33.00 and another as high as $35.00, with a standard deviation of $1.154. The piece highlights the wisdom of crowds nature of targets versus a single view. Current ratings show Strong Buy: 1, Holds: 3, average rating 2.5 on a 1-5 scale. Data from Zacks Investment Research via Quandl; author notes opinions, not Nasdaq.

Ora crosses above average analyst target as ORA trades at $77.30 vs $75.60 target

December 12, 2025, 7:51 AM EST. Ormat Technologies Inc (ORA) trades at $77.30, topping the average 12-month target of $75.60. The move prompts analysts to reassess: either downgrade on valuation or lift targets. The target mix among Zacks-covered analysts ranges from a low of $65.00 to a high of $85.00, with a standard deviation of $7.20, underscoring dispersion in views. With ORA above the average target, investors are urged to reassess fundamentals and decide whether $75.60 is a stepping stone to higher goals or a signal to take profits. The current analyst view shows: 5 ratings: Strong Buy 1, Buy 0, Hold 4, Sell 0, Strong Sell 0; average rating 2.6. Data sourced from Zacks via Quandl.

ORA crosses above average 12-month target as Ormat stock trades at $77.30

December 12, 2025, 7:50 AM EST. Ormat Technologies (ORA) stock traded at $77.30, crossing above the average 12-month target of $75.60. The move puts the focus on whether the target represents a stepping stone to higher values or a potential reset. Across Zacks’ coverage, five analyst targets feed the average, spanning a low of $65.00 and a high of $85.00, with a standard deviation of $7.197. The reaction of analysts may be to raise targets or reassess valuation based on fundamentals. Current consensus sits at an average rating of 2.6 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell), with a mix of Strong Buy and Hold ratings. Data sourced from Zacks Investment Research via Quandl.com.

FTLS Could Be Worth $80.67, Analysts See ~13% Upside From Holdings

December 12, 2025, 7:49 AM EST. By examining ETF Channel’s holdings, FTLS’s implied price derived from its underlying components comes to $80.67 per unit. With FTLS trading near $71.43, analysts imply roughly a 12.93% upside to the ETF based on the average targets of its holdings. The parts with the strongest upside stories include American Superconductor Corp. (AMSC), Dow Inc. (DOW), and Impinj Inc. (PI). AMSC trades at $32.24 with an average target of $65.33 (+102.65%); DOW at $24.58 with a $49.47 target (+101.24%); PI at $152.54 with a $242.10 target (+58.71%). A twelve-month chart of these names accompanies the piece, followed by a table summarizing the targets. The piece ends with questions about whether analysts are justified or overly optimistic, urging further investor research.

FTLS Could Be Worth $80.67: Upside From Underlying Holdings

December 12, 2025, 7:48 AM EST. ETF Channel analyzed FTLS’s underlying holdings to derive a weighted-average implied 12-month target of $80.67 per unit, versus a $71.43 current price-a potential 12.93% upside. Key drivers include holdings with notable upside: AMSC ($32.24→$65.33, 102.65%), DOW ($24.58→$49.47, 101.24%), and PI ($152.54→$242.10, 58.71%). The analysis highlights that analysts’ targets can reflect optimism and may presage downgrades if prospects shift, warranting further research. In short, FTLS’s implied target suggests meaningful upside tied to its components, though actual outcomes depend on evolving company and industry dynamics.

PAC crosses above average analyst target, prompting reassessment of valuation

December 12, 2025, 7:47 AM EST. Grupo Aeroportuario del Pacifico (PAC) traded at $141.54, topping the average 12-month target of $140.60 set by analysts covering the name. When a stock clears a target, analysts may respond by revising higher or downgrading valuation; the move invites a reassessment of what’s driving the strength. Three targets contribute to the current average, with a low of $124.00 and a high of $156.00, and a standard deviation of about $16.03. The question for investors: is the new level a step toward a higher target or a sign the stock is getting stretched? The latest consensus shows a Hold with an average rating of 2.75 on a 1-5 scale, according to Zacks data via Quandl.

PAC crosses above average analyst target as PAC trades at $141.54

December 12, 2025, 7:46 AM EST. Grupo Aeroportuario del Pacifico (PAC) traded at $141.54 as it rose above the average 12-month target of $140.60. The move highlights how analysts react to price crossings: potentially raise targets or reassess valuations. Zacks reports three coverage estimates feeding the average, with one target as low as $124.00 and another as high as $156.00, and a standard deviation of about $16.03. The piece emphasizes the wisdom of crowds in target setting and prompts investors to decide whether $140.60 represents a stepping stone to higher targets or a signal to reduce risk. A breakdown of recent ratings shows a mix of Hold and Sell alongside a 2.75 average rating in the latest Zacks data.

ANF Crosses Above Average Analyst Target as Shares Trade Near $77.88

December 12, 2025, 7:45 AM EST. Abercrombie & Fitch Co (ANF) moved to $77.88, topping the average 12-month target of $77.83. The move highlights how crowdsourced targets can guide investors as analysts could either raise or trim estimates after a target is reached. Across Zacks’ coverage, six targets pull the average, with one analyst at a low $68 and another at a high $85; the spread is reflected in a standard deviation of $6.554. The current analyst mix shows Strong Buy (3) and Hold (5) with an overall average rating of 2.25 on a 1-5 scale, per Zacks via Quandl. Investors may weigh whether the target represents a continued upside or a chance to take chips off the table.

ANF Crosses Above Average Target of $77.83

December 12, 2025, 7:44 AM EST. Abercrombie & Fitch Co (ANF) stock traded at $77.88, nudging above the average analyst target of $77.83 for the next 12 months. The move prompts questions about how analysts will respond-whether to raise targets or reassess valuation. Zacks shows six targets within its universe, with an average target of $77.83 and a wide range from $68.00 to $85.00 (stdev $6.554). The feed underscores the “wisdom of crowds” behind the target. Current coverage breaks down to Strong Buy: 3, Hold: 5, others: 0, with an overall average rating of 2.25 on a 1-to-5 scale. Investors may view the break above the target as a signal to reassess fundamentals and risk.

PAAS Crosses Above Average Analyst Target, Prompting Reassessment of Valuation

December 12, 2025, 7:43 AM EST. Pan American Silver Corp (PAAS) traded at $29.95, briefly topping the average 12-month target of $29.82 set by Zacks-covered analysts. When a stock hits a target, analysts often respond by raising or downgrading the target; the current crossing underscores evolving sentiment amid company fundamentals. Across nine targets in Zacks‘ coverage, estimates range from a low $23.00 to a high $38.00, with a standard deviation of $4.60, illustrating a diverse outlook. The piece emphasizes the wisdom of crowds approach, aggregating multiple viewpoints to gauge fair value. Ratings show: Strong Buy (4), Hold (1), and no sells. The current average rating sits at 1.4. Data provided by Zacks via Quandl; opinions belong to the author.

PAAS Crosses Above Average Analyst Target as Pan American Silver Trades at $29.95

December 12, 2025, 7:42 AM EST. Pan American Silver Corp (PAAS) shares traded at $29.95, just above the average 12-month target of $29.82. When a target is passed, analysts may either downgrade valuation or lift targets if fundamentals justify more upside. Zacks’ coverage shows 9 targets for PAAS, ranging from $23.00 to $38.00, with a standard deviation of about $4.60-an illustration of the crowd’s dispersion. The idea behind the consensus is to synthesize multiple views rather than rely on a single analyst. With PAAS crossing the average target, investors are urged to decide whether $29.82 is a stepping stone to higher horizons or a signal to reassess risk. Data come from Zacks Investment Research via Quandl.com; the latest average rating sits at 1.4 on a 1-5 scale (1 = Strong Buy).

NRG Energy (NYSE:NRG) delivers 479% TSR over 3 years as stock climbs

December 12, 2025, 7:41 AM EST. NRG Energy has outperformed the market over the last three years, delivering a total shareholder return (TSR) of 479%, underpinned by strong dividend payments and capital gains. The stock itself is about 436% higher than three years ago. However, earnings per share declined about 3.1% annually and revenue slipped around 2.6%, signaling mixed fundamentals alongside the rally. The dividend yield sits near 1.0%, offering modest income rather than a driver of momentum. CEO pay is comparatively restrained, but the critical question is whether NRG can sustain earnings growth going forward. For investors, it’s important to weigh TSR and dividends against the underlying earnings trajectory and longer-term sustainability of the rally in NRG Energy.

NRG Energy (NYSE:NRG) Delivers 479% TSR Over 3 Years, Driven by Dividends

December 12, 2025, 7:39 AM EST. Investors chasing big winners found NRG Energy, Inc. (NYSE:NRG) has posted stellar returns: the stock price is up about 436% since 3 years ago, while total shareholder return (TSR) over the period hits 479% thanks to dividends. Over the last 3 years, earnings per share (EPS) declined about 3.1% on an annualized basis, and revenue slipped ~2.6%. The dividend yield sits around 1.0%, providing some support but not a growth engine. The mismatch between earnings/revenue and share-price move suggests market optimism or other drivers. CEO pay is relatively restrained. If you’re evaluating NRG, consider both the earnings trajectory and the TSR contributions from dividends, not just price performance.

Alexander & Baldwin (ALEX): Reassessing Valuation After 32% One-Month Surge

December 12, 2025, 7:38 AM EST. Alexander & Baldwin (ALEX) has surged roughly 32% in the last month, prompting a fresh look at its valuation. With an 18.66% year-to-date return and a roughly 95.8% occupancy on Hawaii properties, the stock’s income profile remains challenged on revenue while margins look resilient. The market appears to price shares near analyst targets, with a fair value around $21.25 and a PE multiple of about 20.7x versus peers. The upside relies on Hawaii’s tight market driving durable NOI growth and premium rents, but risks include tourism weakness and higher redevelopment costs that could compress margins. Investors should weigh intrinsic value against the current price and consider the narrative’s assumptions.

Alexander & Baldwin (ALEX) Valuation Reassessment After 32% Monthly Surge

December 12, 2025, 7:37 AM EST. Alexander & Baldwin (ALEX) has surged about 32% in the last month, signaling renewed appetite for its Hawaii-focused real estate portfolio. While YTD gains approach 18-19% and the one-year return remains strong, the shares now sit near analysts’ fair value, prompting a fresh valuation rethink. The Honolulu-based REIT benefits from Hawaii’s tight land-use constraints, high portfolio occupancy (roughly 95.8%), and steady rental growth that can support ongoing NOI expansion. Yet revenue and earnings pressures persist, and the stock trades at a premium to the global REIT average while lagging higher-growth peers. The narrative sees fair value around $21.25, but a tourism slowdown or higher redevelopment costs could erode margins. Investors should weigh intrinsic value, earnings multiple, and Hawaii market dynamics in assessing risk and upside.

TMC The Metals Company: High Hype, High Risk – Is Ocean Mining Worth a Bet?

December 12, 2025, 7:36 AM EST. TMC The Metals Company has jumped over 800% in a year, but the business remains largely untested. It aims to mine the seafloor, backed by technology development and approvals, yet it currently has no revenue and is burning cash. In Q3 2025 it reported a $55 million operating loss and a $184 million net loss; on a per-share basis, the loss was $0.46. With no operating mines, the investment thesis rests on a story rather than earnings potential. The stock’s volatility is stark: up 800% then retreating, now well below its highs. For most investors, this is a speculative bet on execution and funding, not a reliable path to wealth. Only the most growth-minded investors should consider it, and only with careful due diligence.

Could Buying TMC The Metals Company Today Set You Up for Life? A Risky Ocean-Mining Bet

December 12, 2025, 7:35 AM EST. Investors cheered an 800% rally in TMC The Metals Company, but the business remains unproven: no revenue, sizable operating losses (Q3 2025: net loss of $184 million), and a plan built on underwater mining that hinges on securing approvals and funding. The stock’s history features extreme volatility – sharp swings, a ~50% drawdown from a 52-week high – making the upside uncertain if the critical milestones don’t materialize. This is a high-risk, high-uncertainty bet suitable only for the most aggressive investors who can tolerate a potential loss as the company attempts to transition from a story to a real, scalable operation.

Three Stocks Added to Zacks Rank #5: Strong Sell List (ASH, BIDU, EVH)

December 12, 2025, 7:25 AM EST. Three names were added to Zacks Rank #5 (Strong Sell) today: Ashland Inc. (ASH), Baidu, Inc. (BIDU), and Evolent Health, Inc. (EVH). Each has seen downward revisions to its current year earnings: Ashland down 15% over 60 days, BIDU down 9%, and EVH down 41.1%. The additions keep these stocks on the Zacks Strong Sell list as investors monitor earnings trends. Zacks also previews its evolving Top 10 Stocks for 2025, with potential new leaders to watch as January releases approach. For readers seeking early insights, Zacks offers stock reports and even a download of 5 stocks set to double.

UGP crosses above average 12-month target of $3.83 as shares trade at $3.86

December 12, 2025, 7:22 AM EST. Shares of Ultrapar Participacoes SA (UGP) rose to $3.86, topping the average 12-month target of $3.83 set by analysts. When a stock hits a target, analysts may downgrade or raise their targets; continued strength often reflects underlying fundamentals. The current consensus draws from four Zacks-covered targets, with a wide range: as low as $3.30 and as high as $4.20, yielding a standard deviation of 0.386. The idea behind the ‘wisdom of crowds’ is to aggregate many viewpoints rather than rely on a single expert. With UGP trading above the average target, investors should reassess the story: is $3.83 a stepping stone to a higher target, or is the valuation stretched? Source: Zacks via Quandl.

LSCC Surpasses 12-Month Analyst Target; Analysts Weigh Next Move

December 12, 2025, 7:21 AM EST. Shares of Lattice Semiconductor Corp (LSCC) traded at $91.17, topping the average 12-month target of $90.22. When a target is exceeded, analysts may either downgrade on valuation or lift targets-often reflecting improving fundamentals. Zacks’ coverage shows nine targets for LSCC, with a low of $50 and a high of $110 and a standard deviation of $18.274. The aggregate rating sits at 1.4 on a 1-5 scale (1 = Strong Buy). Current mix: 8 Strong Buy, 2 Hold, zero Sell ratings. The piece highlights a “wisdom of crowds” approach and urges investors to decide whether $90.22 is a stepping stone to higher targets or a signal to take chips off the table. Source: Zacks via Quandl.com.

Sanmina (SANM) crosses above average 12-month target of $84 as analysts weigh next move

December 12, 2025, 7:19 AM EST. In today’s session, Sanmina Corp (SANM) traded at $85.27 and crossed above the average 12-month target of $84.00 set by analysts. The move prompts questions about how analysts will react: potentially downgrade on valuation or raise targets if fundamentals justify upside. Across Zacks’ coverage, there are 4 targets contributing to the average; one outlook sits at $69.00 and another at $90.00, with a standard deviation of about $10. The idea is the wisdom of crowds-the collective view can guide investors as to whether $84.00 is a stepping stone or overextended. Current ratings show 3 holds and no buy/sell signals; the average rating remains 3.0 (neutral). Investors may re-evaluate fundamentals and consider whether to take profits or push for higher targets. Data sourced from Zacks via Quandl.

Enova International (ENVA) Surges 11.7% on Grasshopper Bancorp Deal: What It Means for Potential Gains

December 12, 2025, 7:05 AM EST. Enova International (ENVA) climbed 11.7% to close at $157.92 on notable volume, continuing a four-session rally that touched a new 52-week high of $161.29. The move followed news that ENVA agreed to acquire Grasshopper Bancorp for about $369 million in a cash-and-stock deal, creating a combined platform of online lending and digital banking. The transaction is expected to close in 2H 2026 and to be accretive by more than 15% to adjusted EPS in the first year, rising to 25%+ as synergies are realized. For the upcoming quarter, ENVA is expected to report $3.20 per share on $842.61 million in revenue, with revenue up about 15.5% year over year. The stock carries a Zacks Rank #3 (Hold).

Markets set for a mixed open as cannabis rally lifts stocks and Broadcom weighs on AI outlook

December 12, 2025, 7:04 AM EST. U.S. futures point to a mixed open as cannabis names rally after a report that Trump plans to ease federal restrictions, sending Tilray, Canopy Growth, SNDL and the MSOS ETF higher in premarket trading (Tilray up ~28%, others 13-32%). The report suggests reclassifying marijuana could unlock pharmaceutical approvals and funding. Yet Broadcom fell nearly 6% on AI-related margin concerns, echoing recent tech jitters as investors sift through the pace of AI returns and Oracle’s guidance. The market backdrop remains cautious about the timing of AI payoffs amid elevated spending and a backdrop of a broader tech selloff. Investors balance potential regulatory relief in cannabis with persistent margin pressure in AI-heavy names and a fragile tech mood.

Alps Group Inc (ALPS) Insider Control Tightens as Seng Tham’s Stake Drops 12% on Pullback

December 12, 2025, 7:03 AM EST. Alps Group Inc (NASDAQ: ALPS) shows significant insider control after a recent pullback. The share registry reveals insider control with the top two holders owning about 57% of the company, and CEO Seng Tham alone holding roughly 46%. As a result, the insider group faced the largest losses when the market cap fell by about US$23m. Institutional investment appears absent, a common trait among smaller names, and there is currently little analyst coverage supporting the stock. This ownership mix suggests strong alignment between management and shareholders, but it also raises questions about liquidity and the need for credible growth catalysts to unlock value. Notably, Seng Tham’s holdings declined about 12% in value amid the pullback, underscoring the risk near a concentrated ownership base.